  | Ebo, D. G., Van der Poorten, M. M., Van Gasse, A. L., Schrijvers, R., Hermans, C., Bartiaux, M., Haerynck, F., Willekens, J., Lapeere, H., Moutschen, M., Michel, O., & Sabato, V. (December 2023). Clinical practice of hereditary angioedema in Belgium: opportunities for optimized care. Acta Clinica Belgica, 78 (6), 431 - 437. doi:10.1080/17843286.2023.2213491  Peer Reviewed verified by ORBi |
  | Scheen, A., Louis, R., Lancellotti, P., Jouret, F., Delwaide, J., & Moutschen, M. (November 2023). Vaccination antipneumococcique dans les groupes à risque avec comorbidités : recommandations du Conseil Supérieur de la Santé et critères de remboursement. Revue Médicale de Liège, 78 (11), 665 - 673. Editorial Reviewed verified by ORBi |
  | Misset, B., Piagnerelli, M., Hoste, E., Dardenne, N., Grimaldi, D., Michaux, I., De Waele, E., Dumoulin, A., Jorens, P. G., van der Hauwaert, E., Vallot, F., Lamote, S., Swinnen, W., De Schryver, N., Fraipont, V., de Mey, N., Dauby, N., Layios, N., Mesland, J.-B., ... Laterre, P.-F. (26 October 2023). Convalescent Plasma for Covid-19–Induced ARDS in Mechanically Ventilated Patients. New England Journal of Medicine, 389 (17), 1590-1600. doi:10.1056/nejmoa2209502 Peer Reviewed verified by ORBi |
 | Misset, B., Nguyet, A. D., BERTRAND, A., Piagnerelli, M., Hoste, E., de Waele, E., Dumoulin, A., Jorens, P., van der Hauwaert, E., Vallot, F., Swinnen, W., De Schryver, N., de Mey, N., Layios, N., Mesland, J., Robinet, S., Cavalier, E., Donneau, A.-F., Moutschen, M., & Laterre, P. F. (24 October 2023). Immunological sub-phenotypes and response to Convalescent-Plasma (CP) in COVID-19 induced ARDS (C-ARDS): a hierarchical cluster analysis [Poster presentation]. ESICM LIVES 2023, Milan, Italy. Peer reviewed |
 | Martinez, E., Crevecoeur, S., THIRION, C., GRANDJEAN, J., Fall, P. A., Hayette, M.-P., Moutschen, M., Taminiau, B., Louis, E., & Daube, G. (10 October 2023). Gut Microbiota Associated with Clostridioides difficile Carriage in Three Clinical Groups (Inflammatory Bowel Disease, C. difficile Infection and Healthcare Workers) in Hospital Field. Microorganisms, 11 (10), 2527. doi:10.3390/microorganisms11102527 Peer Reviewed verified by ORBi |
Fombellida-Lopez, C., Pasternak, A. O., Cicilionyté, A., Maes, N., Vanwinge, C., Ormenese, S., Ladang, A., Cavalier, E., Winchester, L., Fletcher, C., SUSIN, F., VAIRA, D., Hayette, M.-P., Reenaers, C., Moutschen, M., & Darcis, G. (11 September 2023). Doubling dolutegravir dosage reduces HIV persistence markers in ART-treated adults [Poster presentation]. HIV Cure Symposium 2023, Gand, Belgium. |
 | COVID-19 Host Genetics Initiative, Rahmouni, S., Georges, M., Moutschen, M., Darcis, G., & Beguin, Y. (September 2023). A second update on mapping the human genetic architecture of COVID-19. Nature, 621 (7977), 7 - E26. doi:10.1038/s41586-023-06355-3 Peer Reviewed verified by ORBi |
 | Kayembe Ntumba, H. C., Bompangue, D., Linard, C., Mandja, B.-A., Batumbo, D., Matunga, M., Muwonga, J., Moutschen, M., Situakibanza, H., & Ozer, P. (28 August 2023). Drivers of the dynamics of the spread of cholera in the Democratic Republic of the Congo, 2000-2018: An eco-epidemiological study. PLoS Neglected Tropical Diseases, 17 (8), 0011597. doi:10.1371/journal.pntd.0011597 Peer Reviewed verified by ORBi |
 | Misset, B., Piagnerelli, M., Hoste, E., Dardenne, N., Grimaldi, D., Michaux, I., De Waele, E., Dumoulin, A., Jorens, P., Layios, N., Moutschen, M., Desmecht, D., Gothot, A., & Laterre, P. F. (14 June 2023). Proceedings of Reanimation 2023, the French Intensive Care Society International CongressCO‐59 Secondary outcomes of the CONFIDENT randomized trial of convalescent plasma therapy with high titers of neutralizing antibodies (NAb) in COVID-ARDS patients [Poster presentation]. SRLF annual meeting 2023, Paris, France. doi:10.1186/s13613-023-01131-y Peer reviewed |
 | Burniat, A., Noël, A., Colige, A., Vanderplasschen, A., de Kerchove d'Exaerde, A., Kupper Cardozo, A., Van Keymeulen, A., Moens, A., Bondue, A., Herpain, A., Marchant, A., Loumaye, A., Beck, B., Van den Heyden, B., Corvilain, B., Lakaye, B., Rogister, B., Malgrange, B., Michiels, C., ... Brunko, E. (2023). Cent scientifiques répliquent à SEA (Suppression des Expériences sur l’Animal vivant) et dénoncent sa désinformation. La Libre Belgique. |
Fombellida-Lopez, C., Pasternak, A. O., Cicilionyté, A., Maes, N., Vanwinge, C., Ormenese, S., Ladang, A., Cavalier, E., Winchester, L., Fletcher, C., SUSIN, F., VAIRA, D., Hayette, M.-P., Reenaers, C., Moutschen, M., & Darcis, G. (21 February 2023). Doubling dolutegravir dosage reduces HIV persistence markers in ART-treated adults [Poster presentation]. Conference on Retroviruses and Opportunistic Infection (CROI 2023), Seattle, United States. |
 | Mayasi Ngongo, N., Kamangu Ntambwe, E., Situakibanza Nani-Tuma, H., Mbula Mambimbi, M., Mandina Ndona, M., Longokolo Mashi, M., Bepouka Izizag, B., Lukiana, T., Odio Ossam, J., Mangala Sonzi, D., Maes, N., Moutschen, M., El Moussaoui, M., & Darcis, G. (2023). Human Immunodeficiency Virus Viral Load Monitoring and Rate of Virologic Suppression Among Patients Receiving Antiretroviral Therapy in Democratic Republic of the Congo, 2013-2020. Open Forum Infectious Diseases, 10 (6), 2-7. doi:10.1093/ofid/ofad242 Peer Reviewed verified by ORBi |
 | Schober, R., Brandus, B., Laeremans, T., Iserentant, G., Rolin, C., Dessilly, G., Zimmer, J., Moutschen, M., Aerts, J. L., Dervillez, X., & Seguin-Devaux, C. (2023). Multimeric immunotherapeutic complexes activating natural killer cells towards HIV-1 cure. Journal of Translational Medicine, 21 (1), 791. doi:10.1186/s12967-023-04669-4 Peer Reviewed verified by ORBi |
 | Amand, M., Adams, P., Schober, R., Iserentant, G., Servais, J.-Y., Moutschen, M., & Seguin-Devaux, C. (2023). The anti-caspase 1 inhibitor VX-765 reduces immune activation, CD4+ T cell depletion, viral load, and total HIV-1 DNA in HIV-1 infected humanized mice. eLife, 12 (February), 83207. doi:10.7554/eLife.83207 Peer Reviewed verified by ORBi |
 | Van der Poorten, M. M., Schrijvers, R., Hermans, C., Bartiaux, M., Haerynck, F., Lapeere, H., Moutschen, M., Michel, O., Sabato, V., Ebo, D. G., & Van Gasse, A. L. (2023). Hereditary angioedema (HAE) in Belgium: results from a national survey. Frontiers in Allergy, 4, 1143897. doi:10.3389/falgy.2023.1143897 Peer Reviewed verified by ORBi |
 | Bernard, D., Taminiau, B., Medlej, M., Moutschen, M., Misset, B., Daube, G., & Rousseau, A.-F. (2023). Oropharyngeal bacterial microbiota analysis at hospital admission: a comparison of COVID-19 and cerebral vascular disease patients. Annals of Intensive Care, 13 (Suppl 1), 048. Peer Reviewed verified by ORBi |
 | El Moussaoui, M., Desmecht, S., Lambert, N., Maes, N., Braghini, J., MARECHAL, N., Quintana, C., BRIQUET, K., Gofflot, S., Toussaint, F., Hayette, M.-P., Vermeersch, P., Lutteri, L., GREGOIRE, C., Beguin, Y., Rahmouni, S., Moutschen, M., Desmecht, D., & Darcis, G. (2023). Cluster Analysis Identifies Distinct Patterns of T-Cell and Humoral Immune Responses Evolution Following a Third Dose of SARS-CoV-2 Vaccine in People Living with HIV. Viruses, 15, 1435. doi:10.3390/v15071435 Peer Reviewed verified by ORBi |
Fombellida-Lopez, C., Pasternak, A. O., Cicilionyté, A., Maes, N., Vanwinge, C., Ormenese, S., Ladang, A., Cavalier, E., Winchester, L., Fletcher, C., SUSIN, F., VAIRA, D., Hayette, M.-P., Reenaers, C., Moutschen, M., & Darcis, G. (23 November 2022). Doubling dolutegravir dosage reduces HIV persistence markers in ART-treated adults [Poster presentation]. Belgium Research on AIDS and HIV Consortium (BREACH 2022), Bruxelles, Belgium. |
 | Zono, B., Sacheli, R., Nani-Tuma, H. S., Mavanga, A., Mwambi, J. A., Etondo, M., Kasumba, D. M., Moutschen, M., Lelo, G. M., & Hayette, M.-P. (20 September 2022). P461 Cryptococcosis screening and isolates characterization in asymptomatic people living with HIV in Kinshasa, DRC [Poster presentation]. ISHAM 2022 Congress. doi:10.1093/mmy/myac072.p461 Peer reviewed |
 | Paridans, M., Monseur, J., Donneau, A.-F., Gillain, N., Husson, E., Leclercq, D., Meuris, C., Darcis, G., Moutschen, M., Saegerman, C., Gillet, L., Bureau, F., Guillaume, M., & Pétré, B. (2022). The Dynamic Relationship between the Intention and Final Decision for the COVID-19 Booster: A Study among Students and Staff at the University of Liège, Belgium. Vaccines. doi:10.3390/vaccines10091485 Peer Reviewed verified by ORBi |
 | El Moussaoui, M., Desmecht, S., Tashkeev, A., Lambert, N., Maes, N., Braghini, J., MARECHAL, N., Quintana, C., BRIQUET, K., Gofflot, S., TOUSSAINT, F., Hayette, M.-P., Vermeersch, P., Lutteri, L., Grégoire, C., Beguin, Y., Rahmouni, S., Moutschen, M., Desmecht, D., & Darcis, G. (05 September 2022). Reduced T-cell response following a third dose of SARS-CoV-2 vaccine in infection-naïve people living with HIV. Journal of Infection, 85, 751-755. doi:10.1016/j.jinf.2022.09.006 Peer Reviewed verified by ORBi |
El Moussaoui, M., Maes, N., Fombellida, K., VAIRA, D., Moutschen, M., & Darcis, G. (02 September 2022). Impact de la pandémie de Covid-19 sur les soins de santé des personnes vivant avec le VIH à Liège, Belgique [Paper presentation]. Congrès annuel de l'Association Latine pour l'Analyse des Systèmes de Santé (CALASS), Barcelone, Spain. Peer reviewed |
 | BONIVER, M., Wotquenne, P., Moutschen, M., & Rousseau, A.-F. (September 2022). La phagothérapie, un complément prometteur dans notre arsenal thérapeutique face aux bactéries multirésistantes. Revue Médicale de Liège, 77 (9), 510 - 515. Peer reviewed |
 | De Leeuw, E.* , Van Damme, K. F. A.* , Declercq, J.* , Bosteels, C.* , Maes, B., Tavernier, S. J., Detalle, L., Smart, T., Glatt, S., Debeuf, N., Deckers, J., Lameire, S., Vandecasteele, S. J., De Neve, N., Demedts, I. K., Govaerts, E., Knoop, C., Vanhove, K., Moutschen, M., ... Lambrecht, B. N. (09 August 2022). Efficacy and safety of the investigational complement C5 inhibitor zilucoplan in patients hospitalized with COVID-19: an open-label randomized controlled trial. Respiratory Research, 23 (202), 1-11. doi:10.1186/s12931-022-02126-2 Peer Reviewed verified by ORBi* These authors have contributed equally to this work. |
 | Pathak, G. A., Karjalainen, J., Stevens, C., Neale, B. M., Daly, M., Ganna, A., Andrews, S. J., Kanai, M., Cordioli, M., Polimanti, R., Harerimana, N., Pirinen, M., Liao, R. G., Chwialkowska, K., Trankiem, A., Balaconis, M. K., Nguyen, H., Solomonson, M., Veerapen, K., ... Baillie, J. K. (03 August 2022). A first update on mapping the human genetic architecture of COVID-19. Nature, 608, 1-E10. doi:10.1038/s41586-022-04826-7 Peer Reviewed verified by ORBi |
 | Maes, N., Rolland, J., Boutin, R., Codet, M., Lecleve, A., Schils, R., THYS, M., Albert, A., Moutschen, M., & Kolh, P. (07 July 2022). Développement et évaluation d’un outil d’aide à la décision clinique pour le suivi des patients hospitalisés pour COVID-19 au CHU de Liège [Paper presentation]. Conférence Francophone en Gestion et Ingénierie des Systèmes Hospitaliers (GISEH), Saint Etienne, France. Peer reviewed |
 | Absil, G., SOUGNE, L., LAHRICHI, D., Collins, P., Meuris, C., Moutschen, M., Nikkels, A., & Orban, C. (July 2022). Variole du singe. Revue Médicale de Liège, 77 (7), 452-455. Editorial Reviewed verified by ORBi |
 | El Moussaoui, M., Maes, N., Hong, S. L., Lambert, N., Gofflot, S., DELLOT, P., Belhadj, Y., Huynen, P., Hayette, M.-P., Meex, C., Bontems, S., Defêche, J., Godderis, L., Molenberghs, G., Meuris, C., Artesi, M., Durkin, K., Rahmouni, S., GREGOIRE, C., ... DARCIS, G. (14 June 2022). Evaluation of Screening Program and Phylogenetic Analysis of SARS-CoV-2 Infections among Hospital Healthcare Workers in Liège, Belgium. Viruses, 14 (6), 1302. doi:10.3390/v14061302 Peer Reviewed verified by ORBi |
 | GREGOIRE, C.* , HUYNEN, P.* , Gofflot, S., Seidel, L., Maes, N., VRANKEN, L., DELCOUR, S., MOUTSCHEN, M., HAYETTE, M.-P., KOLH, P., MELIN, P., & BEGUIN, Y. (13 June 2022). Predictive factors for the presence and long-term persistence of SARS-CoV-2 antibodies in healthcare and university workers. Scientific Reports, 12, 9790. doi:10.1038/s41598-022-13450-4 Peer Reviewed verified by ORBi* These authors have contributed equally to this work. |
 | Misset, B., Piagnerelli Michaël, Hoste Eric, Dardenne, N., Grimaldi D., Michaux, I., Dumoulin, A., Jorens, P., van der Hauwaert, E., de Waele, E., Vallot, F., Lamote, S., Swinnen, W., Fraipont, V., de Mey, N., de Schryver, N., de Wit, S., Layios, N., Mesland, J., ... Laterre, P. F. (June 2022). Convalescent plasma therapy with high titers of neutralizing antibodies to reduce mortality in patients with COVID-19 associated ARDS: the Belgian randomized CONFIDENT trial [Poster presentation]. SIZ Annual Meeting, Bruxelles, Belgium. Peer reviewed |
 | Zono, B.* , SACHELI, R.* , Situakibanza Nani-Tuma, H.* , Kabututu Zakayi, P.* , Ka, A.* , Mbula Mambimbi, M.* , Muendele, G.* , BOREUX, R.* , Landu, N.* , Nzanzu Mudogo, C.* , M'Buze, P.-R.* , MOUTSCHEN, M.* , Meyer, W.* , Mvumbi Lelo, G.* , & HAYETTE, M.-P.*. (19 May 2022). Clinical epidemiology and high genetic diversity amongst Cryptococcus spp. isolates infecting people living with HIV in Kinshasa, Democratic Republic of Congo. PLoS ONE, 17 (5), 0267842. doi:10.1371/journal.pone.0267842 Peer Reviewed verified by ORBi* These authors have contributed equally to this work. |
 | HUYNEN, P.* , GREGOIRE, C.* , GOFFLOT, S., SEIDEL, L., MAES, N., VRANKEN, L., DELCOUR, S., MOUTSCHEN, M., HAYETTE, M.-P., KOLH, P., MELIN, P., & BEGUIN, Y. (25 March 2022). Long-term longitudinal evaluation of the prevalence of SARS-CoV-2 antibodies in healthcare and university workers. Scientific Reports, 12 (1), 5156. doi:10.1038/s41598-022-09215-8 Peer Reviewed verified by ORBi* These authors have contributed equally to this work. |
 | Mayasi, N., Situakibanza, H., Mbula, M., Longokolo, M., Maes, N., Bepouka, B., Ossam, J. O., MOUTSCHEN, M., & DARCIS, G. (11 March 2022). Retention in care and predictors of attrition among HIV-infected patients who started antiretroviral therapy in Kinshasa, DRC, before and after the implementation of the ‘treat-all’ strategy. PLOS Global Public Health, 2 (3), 0000259. doi:10.1371/journal.pgph.0000259 Peer reviewed |
 | Kayembe Ntumba, H. C., Linard, C., Bompangue, D., Muwonga, J., MOUTSCHEN, M., Situakibanza, H., & Ozer, P. (07 February 2022). Modalities and preferred routes of geographic spread of cholera from endemic areas in eastern Democratic Republic of the Congo. PLoS ONE, 17 (2), 0263160. doi:10.1371/journal.pone.0263160 Peer Reviewed verified by ORBi |
 | Devos, T., Van Thillo, Q., Compernolle, V., Najdovski, T., Romano, M., Dauby, N., Jadot, L., Leys, M., Maillart, E., Loof, S., Seyler, L., Moonen, M., MOUTSCHEN, M., Van Regenmortel, N., Ariën, K. K., Barbezange, C., Betrains, A., Garigliany, M.-M., Engelen, M. M., ... DAWn-plasma, I. (February 2022). Early high antibody titre convalescent plasma for hospitalised COVID-19 patients: DAWn-plasma. European Respiratory Journal, 59 (2). doi:10.1183/13993003.01724-2021 Peer Reviewed verified by ORBi |
 | Moutschen, M. (2022). Maladies auto-inflammatoires monogéniques : une introduction sur un mode translationnel aux inflammasomopathies. Revue Médicale de Liège, 77 (5-6), 392 - 398. Editorial Reviewed verified by ORBi |
 | Scheen, A., Louis, R., & Moutschen, M. (2022). Apexxnar®, vaccin anti-pneumococcique conjugué avec 20 sérotypes. Revue Médicale de Liège, 77 (11), 678 - 683. Editorial Reviewed verified by ORBi |
 | Donneau, A.-F.* , Guillaume, M.* , BOURS, V., Dandoy, M., DARCIS, G., Desmecht, D., Diep, A. N., Fievez, L., Garigliany, M.-M., Gillain, N., Husson, E., Michel, F., MOUTSCHEN, M., Paridans, M., Pétré, B., Sabatel, C., Saegerman, C., Tytgat, A., Gillet, L.* , & Bureau, F.*. (2022). University population-based prospective cohort study of SARS-CoV- 2 infection and immunity (SARSSURV-ULiège): a study protocol. BMJ Open. doi:10.1136/bmjopen-2021-055721 Peer Reviewed verified by ORBi* These authors have contributed equally to this work. |
 | Lengele, L., Locquet, M., Moutschen, M., Beaudart, C., Kaux, J.-F., Gillain, S., Shadouh, C., Reginster, J.-Y., & Bruyère, O. (2022). Relationships between malnutrition, sarcopenia, and frailty and the incidence of Covid-19 in older adults: data from the sarcophage cohort. Osteoporosis International, 32 (Suppl 1), 50. Peer Reviewed verified by ORBi |
 | Desmecht, S.* , Tashkeev, A.* , El Moussaoui, M., MARECHAL, N., Perée, H., Tokunaga, Y., Fombellida-Lopez, C., Polese, B., Legrand, C., Wéry, M., Mni, M., Fouillien, N., TOUSSAINT, F., Gillet, L., Bureau, F., LUTTERI, L., HAYETTE, M.-P., MOUTSCHEN, M., MEURIS, C., ... DARCIS, G.*. (2022). Kinetics and persistence of the cellular and humoral immune responses to BNT162b2 mRNA vaccine in SARS-CoV-2-naive and -experienced subjects: impact of booster dose and breakthrough infections. Frontiers in Immunology, 13, 863554. doi:10.3389/fimmu.2022.863554 Peer Reviewed verified by ORBi* These authors have contributed equally to this work. |
 | Egg, D., Rump, I. C., Mitsuiki, N., Rojas-Restrepo, J., Maccari, M.-E., Schwab, C., Gabrysch, A., Warnatz, K., Goldacker, S., Patiño, V., Wolff, D., Okada, S., Hayakawa, S., Shikama, Y., Kanda, K., Imai, K., Sotomatsu, M., Kuwashima, M., Kamiya, T., ... Grimbacher, B. (2022). Therapeutic options for CTLA-4 insufficiency. Journal of Allergy and Clinical Immunology, 149 (2), 736 - 746. doi:10.1016/j.jaci.2021.04.039 Peer Reviewed verified by ORBi |
 | Van Beckhoven, D., Serrien, B., Montourcy, M., Verhofstede, C., Van den Bossche, D., Libois, A., De Geyter, D., Martin, T., Van den Eynde, S., Vuylsteke, B., Darcis, G., van Halem, K., Florence, E., Deblonde, J., Ausselet, N. (Other coll.), Delforge, M.-L. (Other coll.), Demeester, R. (Other coll.), De Munter, P. (Other coll.), Goffard, J.-C. (Other coll.), ... Yombi, J.-C. (Other coll.). (2022). Impact of COVID-19 on the Belgian HIV epidemic: slowdown of HIV transmission and testing and adaptation of care. BMC Infectious Diseases, 22 (1), 901. doi:10.1186/s12879-022-07879-1 Peer Reviewed verified by ORBi |
 | Cambier, M., Henket, M., Frix, A.-N., Gofflot, S., THYS, M., Tomasetti, S., Peired, A., Struman, I., Rousseau, A.-F., Misset, B., Darcis, G., Moutschen, M., Louis, R., Njock, M.-S., Cavalier, E., & Guiot, J. (2022). Increased KL-6 levels in moderate to severe COVID-19 infection. PLoS ONE, 17 (11), 0273107. doi:10.1371/journal.pone.0273107 Peer Reviewed verified by ORBi |
 | Lengele, L., Locquet, M., Moutschen, M., Beaudart, C., KAUX, J.-F., Gillain, S., Reginster, J.-Y., & Bruyère, O. (January 2022). Frailty but not sarcopenia nor malnutrition increases the risk of developing COVID-19 in older community-dwelling adults. Aging Clinical and Experimental Research, 34 (1), 223-234. doi:10.1007/s40520-021-01991-z Peer Reviewed verified by ORBi |
 | Kayembe Ntumba, H. C.* , Linard, C.* , Bompangue, D.* , Muwonga, J.* , MOUTSCHEN, M.* , Situakibanza, H.* , & Ozer, P.*. (19 December 2021). The spread of cholera in western Democratic Republic of the Congo is not unidirectional from East–West: a spatiotemporal analysis, 1973–2018. BMC Infectious Diseases, 21 (1), 1261. Peer Reviewed verified by ORBi* These authors have contributed equally to this work. |
 | Kayembe Ntumba, H. C., Linard, C., Bompangue, D., Muwonga, J., Moutschen, M., Situakibanza, H., & Ozer, P. (19 December 2021). The spread of cholera in western Democratic Republic of the Congo is not unidirectional from East-West: a spatiotemporal analysis, 1973-2018. BMC Infectious Diseases, 21 (1), 1261. doi:10.1186/s12879-021-06986-9 Peer Reviewed verified by ORBi |
 | Zono, B., MOUTSCHEN, M., Situakibanza, H., SACHELI, R., Kabututu, P., Mvumbi, G., & HAYETTE, M.-P. (10 December 2021). Comparaison des caractéristiques cliniques et biologiques des PVVIH présentant une méningite à Cryptococcus neoformans versus C. curvatus/C. laurentii [Paper presentation]. Journées scientifiques PNLS/RDC, Kinshasa, Congo - Kinshasa. |
 | Zono, B., SACHELI, R., Situakibanza, H., Kabututu, P., MOUTSCHEN, M., Mvumbi, G., & HAYETTE, M.-P. (10 December 2021). Épidémiologie clinique et caractérisation moléculaire d’isolats de Cryptococcus spp. infectant les PVVIH à Kinshasa, RDC [Paper presentation]. Journées scientifiques PNLS, Kinshasa, Congo - Kinshasa. |
 | El Moussaoui, M., Lambert, N., MAES, N., Fombellida, K., VAIRA, D., MOUTSCHEN, M., & DARCIS, G. (30 November 2021). Impact of the COVID-19 pandemic situation on HIV care in Liège, Belgium [Poster presentation]. BREACH Symposium 2021, Bruxelles, Belgium. |
 | Muraille, E., De Kerchove d'Exaerde, A., Drion, P., Vanderplasschen, A., Lambermont, B., Rogister, B., Muylkens, B., Vassart, G., Balthazart, J., Pillot, J., Pastushenko, L., Moutschen, M., LEONARD, P., Naccache, P., Costagliola, S., & Guerin, S. (2021). "Opter pour l'obligation vaccinale est un choix de société". Le Vif. L'Express. |
 | Zono, B., MOUTSCHEN, M., SITUAKIBANZA, H., SACHELI, R., MUENDELE, G., KABUTUTU, P., BIAKABUSWA, A., LANDU, N., MVUMBI, G., & Hayette, M.-P. (15 November 2021). Comparison of clinical and biological characteristics of HIV infected patients presenting Cryptococcus neorformans versus C. curvatus /C. laurentii meningitis. BMC Infectious Diseases, 21 (1), 1-10. doi:10.1186/s12879-021-06849-3 Peer Reviewed verified by ORBi |
 | Zono, B., SACHELI, R., Situakibanza, H., Kabututu, P., Mbula, M., Muendele, G., BOREUX, R., Landu, N., Mudogo, C., M'buze, P.-R., Moutschen, M., Mvumbi, G., & Hayette, M.-P. (28 October 2021). Molecular Analysis of Cryptococcus spp. Reveals Species Diversity and Multilocus Sequence Typing Heterogeneity among People Living with HIV in Kinshasa. Journal of Fungi, 7 (916), 42-43. doi:10.3390/jof7110916 Peer Reviewed verified by ORBi |
 | Nakanishi, T., Pigazzini, S., Degenhardt, F., Cordioli, M., Butler-Laporte, G., Maya-Miles, D., Nafría-Jiménez, B., Bouysran, Y., Niemi, M., Palom, A., Ellinghaus, D., Khan, A., Martínez-Bueno, M., Rolker, S., Amitano, S., Tato, L. R., Fava, F., Spinner, C. D., Prati, D., ... consortium, C.-H. (October 2021). Age-dependent impact of the major common genetic risk factor for COVID-19 on severity and mortality. Journal of Clinical Investigation, Online ahead of print.. doi:10.1172/JCI152386 Peer Reviewed verified by ORBi |
 | El Moussaoui, M., Lambert, N., MAES, N., Fombellida, K., VAIRA, D., MOUTSCHEN, M., & DARCIS, G. (2021). Impact of the COVID-19 pandemic situation on HIV care in Liège, Belgium. HIV Research & Clinical Practice. doi:10.1080/25787489.2021.1948773 Peer Reviewed verified by ORBi |
 | Zono, B., MOUTSCHEN, M., Situakibanza, H., Kabututu, P., Mvumbi, G., & Hayette, M.-P. (12 June 2021). Comparison of clinical and biological characteristics of HIV infected patients presenting Cryptococcus neorformans versus C. curvatus /C. laurentii meningitis [Poster presentation]. MYCOLOGY 2021, London - Online, United Kingdom. |
 | Lambert, N., Hansen, I., El Moussaoui, M., GIOT, J.-B., Vercheval, C., LOMMERS, E., SOMJA, J., MOUTSCHEN, M., & MAQUET, P. (2021). Lung and liver sarcoidosis‐like reaction induced by tocilizumab. British Journal of Clinical Pharmacology. doi:10.1111/bcp.14878 Peer Reviewed verified by ORBi |
 | Detry, O., MEURISSE, N., Jouret, F., BLETARD, N., Delwaide, J., & Moutschen, M. (February 2021). Immunosuppression Withdrawal After Liver Transplantation for Common Variable Immunodeficiency. Liver Transplantation, 27 (3), 456-458. doi:10.1002/lt.25873 Peer Reviewed verified by ORBi |
 | Plum, P.-E., Maes, N., Sauvage, A.-S., Frippiat, F., Meuris, C., Uurlings, F., Lecomte, M., Léonard, P., Paquot, N., Fombellida, K., Vaira, D., Moutschen, M., & Darcis, G. (2021). Impact of switch from tenofovir disoproxil fumarate-based regimens to tenofovir alafenamide-based regimens on lipid profile, weight gain and cardiovascular risk score in people living with HIV. BMC Infectious Diseases, 21 (1), 910. doi:10.1186/s12879-021-06479-9 Peer Reviewed verified by ORBi |
 | Nasreddine, R., Florence, E., Moutschen, M., Yombi, J.-C., Goffard, J.-C., Derdelinckx, I., Lacor, P., Vandekerckhove, L., Messiaen, P., Vandecasteele, S., Delforge, M., De Wit, S., & Belgian Research on AIDS and HIV Consortium (BREACH). (2021). Clinical characteristics and outcomes of COVID-19 in people living with HIV in Belgium: A multicenter, retrospective cohort. Journal of Medical Virology, 93 (5), 2971 - 2978. doi:10.1002/jmv.26828 Peer Reviewed verified by ORBi |
 | GUIOT, J., Vaidyanathan, A., DEPREZ, L., Zerka, F., Danthine, D., Frix, A.-N., THYS, M., HENKET, M., CANIVET, G., Mathieu, S., EFTAXIA, E., Lambin, P., Tsoutzidis, N., Miraglio, B., Walsh, S., Moutschen, M., Louis, R., Meunier, P., Vos, W., ... LOVINFOSSE, P. (2021). Development and Validation of an Automated Radiomic CT Signature for Detecting COVID-19. Diagnostics, 11 (1). doi:10.3390/diagnostics11010041 Peer reviewed |
 | Chatterjee, A., Wu, G., Primakov, S., Oberije, C., Woodruff, H., Kubben, P., Henry, R., Aries, M. J. H., Beudel, M., Noordzij, P. G., Dormans, T., Gritters van den Oever, N. C., van den Bergh, J. P., Wyers, C. E., Simsek, S., Douma, R., Reidinga, A. C., de Kruif, M. D., GUIOT, J., ... Lambin, P. (2021). Can predicting COVID-19 mortality in a European cohort using only demographic and comorbidity data surpass age-based prediction: An externally validated study. PLoS ONE, 16 (4), 0249920. doi:10.1371/journal.pone.0249920 Peer Reviewed verified by ORBi |
 | LAMBERMONT, B., SEIDEL, L., THYS, M., CAVALLERI, J., DELANAYE, P., CANIVET, J.-L., KISOKA, G., LAYIOS, N., LEDOUX, D., MASSION, P., MORIMONT, P., Parzibut, G., PIRET, S., ROBINET, S., ROUSSEAU, A.-F., WIESEN, P., Chase, J. G., MEURIS, C., Moutschen, M., & Misset, B. (2021). Comparison of Covid-19 patient management and outcome in a tertiary care center during the first and second waves of the pandemic. Annals of Intensive Care, Suppl 1, 86. Peer Reviewed verified by ORBi |
 | Ngongo, N. M., Nani-Tuma, H. S., Mambimbi, M. M., Mashi, M. L., Izizag, B. B., Ndolumingu, F. K., Maes, N., Moutschen, M., & Darcis, G. (2021). Decrease in late presentation for HIV care in Kinshasa, DRC, 2006-2020. AIDS Research and Therapy, 18 (1), 41. doi:10.1186/s12981-021-00366-8 Peer Reviewed verified by ORBi |
 | Darcis, G., Bouquegneau, A., Maes, N., Thys, M., Henket, M., Labye, F., Rousseau, A.-F., Canivet, P., Desir, C., Calmes, D., Schils, R., De Worm, S., Léonard, P., Meunier, P., Moutschen, M., Louis, R., & Guiot, J. (2021). Long-term clinical follow-up of patients suffering from moderate-to-severe COVID-19 infection: a monocentric prospective observational cohort study. International Journal of Infectious Diseases, 109, 209-216. doi:10.1016/j.ijid.2021.07.016 Peer reviewed |
 | Defêche, J., AZARZAR, S., Mesdagh, A., DELLOT, P., Tytgat, A., Bureau, F., Gillet, L., Belhadj, Y., BONTEMS, S., HAYETTE, M.-P., Schils, R., Rahmouni, S., ERNST, M., MOUTSCHEN, M., & DARCIS, G. (2021). In-Depth Longitudinal Comparison of Clinical Specimens to Detect SARS-CoV-2. Pathogens (Basel, Switzerland), 10 (11). doi:10.3390/pathogens10111362 Peer reviewed |
 | D'Antonio, M., Nguyen, J. P., Arthur, T. D., Matsui, H., COVID-19 Host Genetics Initiative, D'Antonio-Chronowska, A., Frazer, K. A., & Moutschen, M. (Other coll.). (2021). SARS-CoV-2 susceptibility and COVID-19 disease severity are associated with genetic variants affecting gene expression in a variety of tissues. Cell Reports, 37 (7), 110020. doi:10.1016/j.celrep.2021.110020 Peer Reviewed verified by ORBi |
 | Niemi, M., Gazon, H., JUSZCZAK, D., FADEUR, M., CAMBY, S., MEURIS, C., THYS, M., JACQUES, J., HENKET, M., BEGUIN, Y., Rahmouni, S., Lebrun, M., MOUTSCHEN, M., Misset, B., DARCIS, G., GUIOT, J., AZARZAR, S., DELLOT, P., GOFFLOT, S., ... HUYNEN, P. (Other coll.). (2021). Mapping the human genetic architecture of COVID-19. Nature, 600, 472-477. doi:10.1038/s41586-021-03767-x Peer Reviewed verified by ORBi |
 | Jacques, S., Arjomand, A., Perée, H., COLLINS, P., Mayer, A., Lavergne, A., Wéry, M., Mni, M., Hego, A., Thuillier, V., Becker, G., Bahri, M. A., Plenevaux, A., Di Valentin, E., Oury, C., MOUTSCHEN, M., Delvenne, P., Paquot, N., & Rahmouni, S. (2021). Dual‑specificity phosphatase 3 deletion promotes obesity, non‑alcoholic steatohepatitis and hepatocellular carcinoma. Scientific Reports, 11, 5817. doi:10.1038/s41598-021-85089-6 Peer Reviewed verified by ORBi |
 | Adams, P., Fievez, V., Schober, R., Amand, M., Iserentant, G., Rutsaert, S., Dessilly, G., Vanham, G., Hedin, F., Cosma, A., Moutschen, M., Vandekerckhove, L., & Seguin-Devaux, C. (2021). CD32+CD4+ memory T cells are enriched for total HIV-1 DNA in tissues from humanized mice. iScience, 24 (1), 101881. doi:10.1016/j.isci.2020.101881 Peer Reviewed verified by ORBi |
 | Plum, P.-E., Darcis, G., & Moutschen, M. (2021). L’arrivée des bithérapies dans le traitement du virus de l’immunodéficience humaine : la fin d’un dogme? Revue Médicale de Liège, 76 (9), 677 - 682. Editorial Reviewed verified by ORBi |
 | Meuris, C., Kremer, C., Geerinck, A., Locquet, M., Bruyère, O., Defêche, J., Meex, C., Hayette, M.-P., Duchene, L., Dellot, P., Azarzar, S., Maréchal, N., Sauvage, A.-S., Frippiat, F., Giot, J.-B., Léonard, P., Fombellida, K., Moutschen, M., Durkin, K., ... Darcis, G. (2021). Transmission of SARS-CoV-2 After COVID-19 Screening and Mitigation Measures for Primary School Children Attending School in Liège, Belgium. JAMA Network Open, 4 (10), 2128757. doi:10.1001/jamanetworkopen.2021.28757 Peer Reviewed verified by ORBi |
 | Ngongo, N. M., Darcis, G., Nanituna, H. S., Mambimbi, M. M., Maes, N., Mashi, M. L., Bepouka Izizag, B., Moutschen, M., & Lepira Bompeka, F. (2021). Longitudinal analysis of sociodemographic, clinical and therapeutic factors of HIV-infected individuals in Kinshasa at antiretroviral therapy initiation during 2006-2017. PLoS ONE, 16 (11), 0259073. doi:10.1371/journal.pone.0259073 Peer Reviewed verified by ORBi |
 | Ngongo, N. M., Nani-Tuma, H. S., Mambimbi, M. M., Mashi, M. L., Izizag, B. B., Maes, N., Moutschen, M., & Darcis, G. (2021). Progressive phasing out of baseline CD4+ cell count testing for people living with HIV in Kinshasa, Democratic Republic of the Congo. AIDS (London, England), 35 (5), 841-843. doi:10.1097/QAD.0000000000002802 Peer reviewed |
 | CALMES, D., Graff, S., MAES, N., Frix, A.-N., THYS, M., BONHOMME, O., Berg, J., DEBRUCHE, M., GESTER, F., HENKET, M., PAULUS, V., DUYSINX, B., HEINEN, V., NGUYEN DANG, D., PAULUS, A., QUAEDVLIEG, V., VAILLANT, F., VAN CAUWENBERGE, H., MALAISE, M., ... SCHLEICH, F. (2021). Asthma and COPD Are Not Risk Factors for ICU Stay and Death in Case of SARS-CoV2 Infection. Journal of Allergy and Clinical Immunology: In Practice, 9 (1), 160-169. doi:10.1016/j.jaip.2020.09.044 Peer Reviewed verified by ORBi |
 | Misset, B., Hoste, E., Donneau, A.-F., Grimaldi, D., Meyfroidt, G., Moutschen, M., Compernolle, V., Gothot, A., Desmecht, D., Garigliany, M.-M., Najdovski, T., & Laterre, P. F. (2021). Correction to: A multicenter randomized trial to assess the efficacy of CONvalescent plasma therapy in patients with Invasive COVID-19 and acute respiratory failure treated with mechanical ventilation: the CONFIDENT trial protocol (BMC Pulmonary Medicine, (2020), 20, 1, (317), 10.1186/s12890-020-01361-x). BMC Pulmonary Medicine, 21 (1). doi:10.1186/s12890-021-01574-8 Peer Reviewed verified by ORBi |
 | Frix, A.-N., Schoneveld, L., LADANG, A., HENKET, M., DUYSINX, B., VAILLANT, F., Misset, B., Moutschen, M., Louis, R., Cavalier, E., & Guiot, J. (November 2020). Could KL-6 levels in COVID-19 help to predict lung disease? Respiratory Research, 21 (309). doi:10.1186/s12931-020-01560-4 Peer Reviewed verified by ORBi |
 | Fombellida-Lopez, C., Chaslain, A., SUSIN, F., VAIRA, D., Moutschen, M., & DARCIS, G. (September 2020). Obstacles à la guérison de l'infection par le VIH. Partie 1 : les réservoirs latents. Revue Médicale de Liège, 75 (9), 573-577. Peer reviewed |
 | Chaslain, A., Fombellida-Lopez, C., SUSIN, F., VAIRA, D., Moutschen, M., & Darcis, G. (September 2020). Obstacles à la guérison de l'infection par le VIH. Partie 2 : la réplication continue malgré le traitement. Revue Médicale de Liège, 75 (9), 582-587. Peer reviewed |
 | Wu, G., Yang, P., Xie, Y., Woodruff, H. C., Rao, X., Guiot, J., Frix, A.-N., Louis, R., Moutschen, M., Li, J., Li, J., Yan, C., Du, D., Zhao, S., Ding, Y., Liu, B., Sun, W., Albarello, F., D'Abramo, A., ... Lambin, P. (2020). Development of a Clinical Decision Support System for Severity Risk Prediction and Triage of COVID-19 Patients at Hospital Admission: an International Multicenter Study. European Respiratory Journal. doi:10.1183/13993003.01104-2020 Peer Reviewed verified by ORBi |
 | Misset, B., Hoste, E., Donneau, A.-F., Grimaldi, D., Meyfroidt, G., MOUTSCHEN, M., Compernolle, V., GOTHOT, A., Desmecht, D., Garigliany, M.-M., Najdovski, T., & Laterre, P.-F. (2020). A multicenter randomized trial to assess the efficacy of CONvalescent plasma therapy in patients with Invasive COVID-19 and acute respiratory failure treated with mechanical ventilation: the CONFIDENT trial protocol. BMC Pulmonary Medicine. doi:10.1186/s12890-020-01361-x Peer Reviewed verified by ORBi |
 | El Moussaoui, M., Lambert, I., MAES, N., SAUVAGE, A.-S., FRIPPIAT, F., MEURIS, C., UURLINGS, F., LECOMTE, M., LEONARD, P., Fombellida, K., VAIRA, D., Vercheval, C., Moutschen, M., & Darcis, G. (2020). Evolution of Drug Interactions With Antiretroviral Medication in People With HIV. Open Forum Infectious Diseases, 7 (11), 416. doi:10.1093/ofid/ofaa416 Peer Reviewed verified by ORBi |
 | Devos, T., Geukens, T., Schauwvlieghe, A., Ariën, K. K., Barbezange, C., Cleeren, M., Compernolle, V., Dauby, N., Desmecht, D., Grimaldi, D., Lambrecht, B. N., Luyten, A., Maes, P., Moutschen, M., Romano, M., Seyler, L., Nevessignsky, M. T., Vandenberghe, K., van Griensven, J., ... Meyfroidt, G. (2020). A randomized, multicentre, open-label phase II proof-of-concept trial investigating the clinical efficacy and safety of the addition of convalescent plasma to the standard of care in patients hospitalized with COVID-19: the Donated Antibodies Working against nCoV (DAWn-Plasma) trial. Trials, 21 (1), 981. doi:10.1186/s13063-020-04876-0 Peer Reviewed verified by ORBi |
 | DARCIS, G., VAIRA, D., & MOUTSCHEN, M. (2020). Impact of coronavirus pandemic and containment measures on HIV diagnosis. Epidemiology and Infection. doi:10.1017/S0950268820001867 Peer reviewed |
 | GUIOT, J., HENKET, M., Frix, A.-N., Delvaux, M., DENIS, A., GILTAY, L., THYS, M., GESTER, F., MOUTSCHEN, M., CORHAY, J.-L., LOUIS, R., LAMBERMONT, B. (Other coll.), & MALAISE, O. (Other coll.). (2020). Single-center experience of patients with interstitial lung diseases during the early days of te COVID-19 pandemic. Respiratory Investigation, 58 (6), 437-9. doi:10.1016/j.resinv.2020.08.006 Peer Reviewed verified by ORBi |
 | PIRARD, C., Léonard, P., Plum, P.-E., Struvay, S., & Moutschen, M. (2020). Les dérivés combinés de l'artémisinine : une avancée thérapeutique dans le contrôle du paludisme non compliqué à Plasmodium falciparum. Revue Médicale de Liège, 75 (5-6), 362 - 365. Editorial Reviewed verified by ORBi |
 | Scheen, A., & Moutschen, M. (2020). Le point sur les stratégies médicamenteuses contre la COVID-19 : entre espoirs et déceptions. Revue Médicale de Liège, 75 (S1), 162-169. Peer reviewed |
 | Ilbert, C., SABATIELLO, M., KURTH, W., Longrée, L., MOUTSCHEN, M., & DARCIS, G. (2020). Le syndrome de Schnitzler. Revue Médicale de Liège. Peer reviewed |
 | Mina, M., MOUTSCHEN, M., & MEURIS, C. (13 December 2019). Clinical case : chronic granulomatous disease [Paper presentation]. Annual Congress of the Belgian Society of Internal Medicine, Bruxelles, Belgium. Peer reviewed |
| Mina, M., MOUTSCHEN, M., & MEURIS, C. (13 December 2019). Clinical case : chronic granulomatous disease [Paper presentation]. Annual Congress of the Belgian Society of Internal Medicine, Bruxelles, Belgium. Peer reviewed |
 | El Moussaoui, M., Lambert, I., MAES, N., SAUVAGE, A.-S., FRIPPIAT, F., MEURIS, C., UURLINGS, F., LECOMTE, M., LEONARD, P., FOMBELLIDA, K., VAIRA, D., Vercheval, C., MOUTSCHEN, M., & DARCIS, G. (22 November 2019). Evolution of drug interactions with antiretroviral medications in HIV-infected patients [Poster presentation]. 8th BREACH SYMPOSIUM, Liège, Belgium. |
El Moussaoui, M., Lambert, I., MAES, N., SAUVAGE, A.-S., FRIPPIAT, F., MEURIS, C., UURLINGS, F., LECOMTE, M., LEONARD, P., Fombellida, K., VAIRA, D., Vercheval, C., MOUTSCHEN, M., & DARCIS, G. (08 November 2019). Evolution of drug interactions with antiretroviral medications in HIV-infected patients [Paper presentation]. 17th European AIDS Conference, Bâle, Switzerland. |
 | Pirotte, B., FRIPPIAT, F., DARCIS, G., Rassenfosse, M., Fombellida, K., MAES, N., Moerman, F., & MOUTSCHEN, M. (2019). Etude des motifs d'admission au service des Urgences d'une cohorte de patients. Revue Médicale de Liège. Peer reviewed |
 | Eron, J. J., Orkin, C., Cunningham, D., Pulido, F., Post, F. A., De Wit, S., Lathouwers, E., Hufkens, V., Jezorwski, J., Petrovic, R., Brown, K., Van Landuyt, E., Opsomer, M., EMERALD study group, & Moutschen, M. (Other coll.). (2019). Week 96 efficacy and safety results of the phase 3, randomized EMERALD trial to evaluate switching from boosted-protease inhibitors plus emtricitabine/tenofovir disoproxil fumarate regimens to the once daily, single-tablet regimen of darunavir/cobicistat/emtricitabine/tenofovir alafenamide (D/C/F/TAF) in treatment-experienced, virologically-suppressed adults living with HIV-1. Antiviral Research, 170, 104543. doi:10.1016/j.antiviral.2019.104543 Peer Reviewed verified by ORBi |
 | DARCIS, G., MAES, N., Pasternak, A., SAUVAGE, A.-S., FRIPPIAT, F., MEURIS, C., UURLINGS, F., LECOMTE, M., LEONARD, P., El Moussaoui, M., Fombellida, K., VAIRA, D.* , & MOUTSCHEN, M.*. (2019). Detectability of HIV residual Viremia despite therapy is highly associated with treatment with a protease inhibitor-based combination antiretroviral therapy. Antimicrobial Agents and Chemotherapy. doi:10.1128/AAC.01902-19 Peer Reviewed verified by ORBi* These authors have contributed equally to this work. |
 | Farhat, K., Bodart, G., Moutschen, M., Salvatori, R., Martens, H., & Geenen, V. (December 2018). Growth hormone (GH) deficient mice with GHRH ablation are severely deficient in vaccine and immune responses against Streptococcus pneumoniae. Acta Clinica Belgica, 73 (6 (Suppl.2)). Peer Reviewed verified by ORBi |
 | Farhat, K., Bodart, G., Charlet-Renard, J. D. C., Desmet, C., Moutschen, M., Beguin, Y., Baron, F., Melin, P., Quatresooz, P., Parent, A.-S., Desmecht, D., Sirard, J.-C., Salvatori, R., Martens, H., & Geenen, V. (02 October 2018). Growth hormone (GH) deficient mice with GHRH ablation are severely deficient in vaccine and immune responses against Streptococcus pneumoniae. Frontiers in Immunology, 9, 2175. doi:10.3389/fimmu.2018.02175 Peer Reviewed verified by ORBi |
 | DARCIS, G., Lambert, I., SAUVAGE, A.-S., FRIPPIAT, F., MEURIS, C., UURLINGS, F., LECOMTE, M., LEONARD, P., GIOT, J.-B., fombellida, K., VAIRA, D., & MOUTSCHEN, M. (2018). Factors associated with late presentation for HIV care in a single Belgian reference center: 2006-2017. Scientific Reports. doi:10.1038/s41598-018-26852-0 Peer Reviewed verified by ORBi |
 | Farhat, K., Bodart, G., Desmet, C., Moutschen, M., Beguin, Y., Baron, F., Salvatori, R., Martens, H., & Geenen, V. (20 March 2018). GHRH-deleted Mice Are Severely Deficient in Vaccine And Immunological Responses Against Streptococcus Pneumoniae [Paper presentation]. ENDO 2018, Chicago, United States. |
 | Calderaro, J., Letouze, E., Bayard, Q., Boulai, A., Renault, V., Deleuze, J.-F., Bestard, O., Franco, D., Zafrani, E.-S., Nault, J.-C., Moutschen, M., & Zucman-Rossi, J. (2018). Systemic AA Amyloidosis Caused by Inflammatory Hepatocellular Adenoma. New England Journal of Medicine, 379 (12), 1178-1180. doi:10.1056/NEJMc1805673 Peer Reviewed verified by ORBi |
 | De Wit, S., Florence, E., Vandekerckhove, L., Vandercam, B., Goffard, J.-C., Van Wijngaerden, E., Moutschen, M., Demeester, R., Thilakarathne, P., Piryns, H., & for the BREACH* Consortium. (2018). Long-term use of darunavir/ritonavir-containing regimens in daily practice in Belgium: retrospective observational cohort data of 1701 HIV-patients. Acta Clinica Belgica, 1-7. doi:10.1080/17843286.2018.1458428 Peer Reviewed verified by ORBi |
 | Egg, D., Schwab, C., Gabrysch, A., Arkwright, P. D., Cheesman, E., Giulino-Roth, L., Neth, O., Snapper, S., Okada, S., Moutschen, M., Delvenne, P., Pecher, A.-C., Wolff, D., Kim, Y.-J., Seneviratne, S., Kim, K.-M., Kang, J.-M., Ojaimi, S., McLean, C., ... Grimbacher, B. (2018). Increased risk for malignancies in 131 affected CTLA4 mutation carriers. Frontiers in Immunology, 9 (SEP). doi:10.3389/fimmu.2018.02012 Peer Reviewed verified by ORBi |
 | DARCIS, G., & Moutschen, M. (2018). Wild-type HIV infection despite PrEP: a lot to learn from a case report. The Lancet HIV, 5 (1), 10. doi:10.1016/S2352-3018(17)30212-6 Peer Reviewed verified by ORBi |
 | de Worm, S., GIOT, J.-B., Courtoy, C., Gillet, E., Amrane, S., Huynen, P., Van Esbroeck, M., Prudent, E., Lepidi, H., Million, M., Moutschen, M., & Raoult, D. (2018). A case of giant cell arteritis associated with culture-proven Coxiella burnetii aortitis. International Journal of Infectious Diseases, 69, 50-54. doi:10.1016/j.ijid.2018.01.028 Peer Reviewed verified by ORBi |
 | Schwab, C., Gabrysch, A., Olbrich, P., Patino, V., Warnatz, K., Wolff, D., Hoshino, A., Kobayashi, M., Imai, K., Takagi, M., Dybedal, I., Haddock, J. A., Sansom, D. M., Lucena, J. M., Seidl, M., Schmitt-Graeff, A., Reiser, V., Emmerich, F., Frede, N., ... Grimbacher, B. (2018). Phenotype, penetrance, and treatment of 133 cytotoxic T-lymphocyte antigen 4-insufficient subjects. Journal of Allergy and Clinical Immunology, 142 (6), 1932-1946. doi:10.1016/j.jaci.2018.02.055 Peer Reviewed verified by ORBi |
 | De Benedetti, F., Gattorno, M., Anton, J., Ben-Chetrit, E., Frenkel, J., Hoffman, H. M., Kone-Paut, I., Lachmann, H. J., Ozen, S., Simon, A., Zeft, A., Calvo Penades, I., Moutschen, M., Quartier, P., Kasapcopur, O., Shcherbina, A., Hofer, M., Hashkes, P. J., Van der Hilst, J., ... Junge, G. (2018). Canakinumab for the Treatment of Autoinflammatory Recurrent Fever Syndromes. New England Journal of Medicine, 378 (20), 1908-1919. doi:10.1056/NEJMoa1706314 Peer Reviewed verified by ORBi |
 | Moutschen, M., Martens, H., & Geenen, V. (2017). Immunosenescence and infectious diseases. In J.-P. Michel, B. L. Beattie, F. C. Martin, ... J. D. Walston (Eds.), Oxford Textbook of Geriatric Medicine - 3rd Edition (10.1093/med/9780198701590.001.0001, pp. 1-17). Oxford, United Kingdom: Oxford University Press. doi:10.1093/med/9780198701590.003.0079 Peer reviewed |
 | DE VOEGHT, A., Martens, H., RENARD, J. D. C., VAIRA, D., Debruche, M., Simonet, J., Geenen, V., MOUTSCHEN, M., & DARCIS, G. (2017). Exploring the link between innate immune activation and thymic function by measuring sCD14 and TRECs in HIV patients living in Belgium. PLoS ONE. doi:10.1371/journal.pone.0185761 Peer Reviewed verified by ORBi |
 | Vandereyken, M., Jacques, S., Van Overmeire, E., Amand, M., Rocks, N., Delierneux, C., Singh, P., Singh, M., GHUYSEN, C., Wathieu, C., Zurashvili, T., Sounni, N. E., Moutschen, M., Gilles, C., Oury, C., Cataldo, D., Van Ginderachter, J. A., & Rahmouni, S. (2017). Dusp3 deletion in mice promotes experimental lung tumour metastasis in a macrophage dependent manner. PLoS ONE. doi:10.1371/journal.pone.0185786 Peer Reviewed verified by ORBi |
 | DARCIS, G., Van der Auwera, G., GIOT, J.-B., Hayette, M.-P., Tassin, F., Arrese Estrada, J., Cnops, L., Moutschen, M., de Leval, L., & LEONARD, P. (07 July 2017). Recurrence of visceral and muco-cutaneous leishmaniasis in a patient under immunosuppressive therapy. BMC Infectious Diseases, 17. doi:10.1186/s12879-017-2571-x Peer Reviewed verified by ORBi |
 | Farhat, K., Bodart, G., RENARD, J. D. C., Desmet, C., MOUTSCHEN, M., Beguin, Y., Baron, F., Salvatori, R., Geenen, V., & Martens, H. (23 May 2017). A surprising and dramatic neuroendocrine-immune phenotype of mice deficient in Growth Hormone-Releasing Hormone (GHRH) [Poster presentation]. European Congress of Endocrinology, Lisbonne, Portugal. doi:10.1530/endoabs.49.EP883 |
 | Farhat, K., Bodart, G., Renard, C., Desmet, C., MOUTSCHEN, M., BARON, F., Beguin, Y., Salvatori, R., Martens, H., & GEENEN, V. (May 2017). A surprising and dramatic neuroendocrine-immune phenotype of mice deficient in Growth Hormone-Releasing Hormone (GHRH) [Poster presentation]. The 19th European Congress of Endocrinology, Lisbon, Portugal. |
 | HUART, J., GROSCH, S., BOVY, C., Moutschen, M., & Krzesinski, J.-M. (April 2017). IgG4-related membranous glomerulonephritis and generalized lymphadenopathy without pancreatitis: a case report. BMC Nephrology, 18, 139. doi:10.1186/s12882-017-0561-2 Peer Reviewed verified by ORBi |
| BRULS, S., Courtois, A., DELVENNE, P., HUSTINX, R., MOUTSCHEN, M., de Leval, L., Defraigne, J.-O., & SAKALIHASAN, N. (2017). IgG4-related disease causing rapid evolution of a severe aortic valvular stenosis. Annals of Thoracic Surgery. doi:10.1016/j.athoracsur.2016.08.045 Peer Reviewed verified by ORBi |
 | DARCIS, G., & Moutschen, M. (2017). Guérir l'infection par le VIH: Un objectif réaliste? Revue Médicale de Liège, 72 (9), 388-392. Peer reviewed |
 | Narinx, J., Poncin, A., HUYNEN, P., Moutschen, M., & GIOT, J.-B. (2017). Atteinte hépato-splénique et bartonellose systémique chez une patiente immunocompétente. Revue Médicale de Liège, 72 (7-8), 331-335. Peer reviewed |
 | Vandereyken, M., Singh, P., Wathieu, C., Jacques, S., Zurashvili, T., Dejager, L., Amand, M., Musumeci, L., Singh, M., MOUTSCHEN, M., Libert, C., & Rahmouni, S. (2017). Dual-Specificity Phosphatase Deletion Protects Female, but Not Male, Mice from Endotoxemia- and Polymicrobial-Induced Septic Shock. Journal of Immunology. doi:10.4049/jimmunol.1602092 Peer Reviewed verified by ORBi |
 | DARCIS, G., & Moutschen, M. (2017). The effect of treatment simplification on HIV reservoirs. The Lancet HIV, 4 (8), 328-e329. doi:10.1016/S2352-3018(17)30135-2 Peer Reviewed verified by ORBi |
 | Mayaki, Z., Seydou, M., Moutschen, M., Albert, A., Dardenne, N., Sondag, D., Gossens, D., & Gérard, C. (2017). Rapid tests and transfusion safety in Niamey, Niger. Médecine et Santé Tropicales, 27 (1), 95-100. doi:10.1684/mst.2017.0663 Peer Reviewed verified by ORBi |
 | Farhat, K., Bodart, G., Martens, H., Baron, F., Beguin, Y., Moutschen, M., Salvatori, R., & Geenen, V. (2017). A surprising and dramatic neuroendocrine-immune phenotype of mice deficient in Growth Hormone-Releasing Hormone (GHRH). Neuroimmunomodulation. Peer Reviewed verified by ORBi |
 | Mukeba-Tshialala, D., Nachega, J. B., Mutombo-Tshingwali, M., Arendt, V., Gilson, G., & Moutschen, M. (2017). Obésité, hypertension artérielle, hypercholestérolémie et diabète non traités chez les adultes infectés ou pas par le VIH à Mbuji-Mayi (République démocratique du Congo). Bulletin de la Société de Pathologie Exotique, 110 (5), 301-309. doi:10.1007/s13149-017-0561-2 Peer Reviewed verified by ORBi |
 | Gunter, J., Callens, S., De Wit, S., Goffard, J.-C., Moutschen, M., DARCIS, G., MEURIS, C., van den Bulcke, C., Fombellida, K., del Forge, M., Razavi, H., & Wyndham-Thomas, C. (2017). Prevalence of non-infectious comorbidities in the HIV-positive population in Belgium: a multicenter, retrospective study. Acta Clinica Belgica, 1-4. doi:10.1080/17843286.2017.1339965 Peer Reviewed verified by ORBi |
 | Deleixhe, B., FRIPPIAT, F., Léonard, P., WITHOFS, N., MEEX, C., Pierard, L., & Moutschen, M. (2017). Endocardite à aggregatibacter aphrophilus sur prothèses valvulaires. Revue Médicale de Liège, 72 (12), 522-528. Peer reviewed |
 | Vogl, C., Butola, T., Haag, N., Hausrat, T. J., Leitner, M. G., Moutschen, M., Lefèbvre, P., Speckmann, C., Garrett, L., Becker, L., Fuchs, H., Hrabe de Angelis, M., Nietzsche, S., Kessels, M., Oliver, D., Kneussel, M., Kilimann, M. W., & Strenzke, N. (2017). The BEACH protein LRBA is required for hair bundle maintenance in cochlear hair cells and for hearing. EMBO Reports, 18 (11), 2015-2029. doi:10.15252/embr.201643689 Peer Reviewed verified by ORBi |
 | Adawaye, C., Fokam, J., Kamangu, E., Alio, H. M., Chahad, A. M., SUSIN, F., Moussa, A. M., Bertin, T. H. Z., Tidjani, A., VAIRA, D., & Moutschen, M. (2017). Virological response, HIV-1 drug resistance mutations and genetic diversity among patients on first-line antiretroviral therapy in N'Djamena, Chad: Findings from a cross-sectional study. BMC Research Notes, 10 (1). doi:10.1186/s13104-017-2893-1 Peer Reviewed verified by ORBi |
Jacques, S., Arjomand, A., Vandereyken, M., Moutschen, M., Oury, C., & Rahmouni, S. (08 December 2016). DUSP3 genetic deletion predispose to obesity-induced hepatocellular carcinoma [Poster presentation]. Séminaire des chercheurs Télévie, Louvain, Belgium. |
 | Farhat, K., Bodart, G., Desmet, C., Moutschen, M., Salvatori, R., Geenen, V., & Martens, H. (07 November 2016). Severe deficiency of the somatotrope GHRH/GH/IGF-1 axis induces a dramatic susceptibility to Streptococcus pneumoniae infection [Poster presentation]. Growth Hormone Research Society (GRS) and IGF Society, Tel Aviv, Israel. |
 | Farhat, K., Bodart, G., RENARD, J. D. C., Desmet, C., Moutschen, M., Baron, F., Beguin, Y., Salvatori, R., Geenen, V., & Martens, H. (November 2016). Severe deficiency of the somatotrope GHRH/GH/IGF1 axis induces a dramatic susceptibility to Streptococcus pneumoniae infection [Paper presentation]. 50e Congrès de la Société Française d'Immunologie (SFI), Paris, France. |
 | DE VOEGHT, A., Maes, N., & Moutschen, M. (27 March 2016). sCD14 is not a bona-fide biomarker of microbial translocation in HIV-1 infected Africans living in Belgium. AIDS, 30 (6), 921-4. doi:10.1097/QAD.0000000000000996 Peer Reviewed verified by ORBi |
 | DE VOEGHT, A., SAUVAGE, A.-S., GENSBURGER, M., GIOT, J.-B., & Moutschen, M. (2016). Tuberculose miliaire chez une patiente sous adalimumab. Revue Médicale de Liège, 71 (7-8), 328-331. Peer reviewed |
 | SAUVAGE, A.-S., DARCIS, G., & Moutschen, M. (2016). Actualité thérapeutique dans le VIH: Le ténofovir alafénamide. Revue Médicale Suisse, 12 (527), 1367-1369. Peer Reviewed verified by ORBi |
 | van der Hilst, J. C., Moutschen, M., Messiaen, P. E., Lauwerys, B. R., & Vanderschueren, S. (2016). Efficacy of anti-IL-1 treatment in familial Mediterranean fever: a systematic review of the literature. Biologics: Targets and Therapy, 10, 75-80. doi:10.2147/BTT.S102954 Peer Reviewed verified by ORBi |
 | Moutschen, M. (2016). Prevenar 13®, un vaccin conjugué anti-pneumococcique pour la prévention des infections à pneumocoque chez les adultes à risque. Revue Médicale de Liège, 71 (4), 204-209. Peer reviewed |
 | Mayaki, Z., Kabo, R., Moutschen, M., Albert, A., Dardenne, N., Sondag, D., & Gérard, C. (2016). Knowledge, attitudes and clinical practice of blood products prescribers in Niamey. Transfusion Clinique et Biologique, 23 (2), 78-85. doi:10.1016/j.tracli.2015.11.007 |
 | Durel, C.-A., Aouba, A., Bienvenu, B., Deshayes, S., Coppere, B., Gombert, B., Acquaviva-Bourdain, C., Hachulla, E., Lecomte, F., Touitou, I., Ninet, J., Philit, J.-B., Messer, L., Brouillard, M., Girard-Madoux, M.-H., Moutschen, M., Raison-Peyron, N., Hutin, P., Duffau, P., ... Hot, A. (2016). Observational Study of a French and Belgian Multicenter Cohort of 23 Patients Diagnosed in Adulthood With Mevalonate Kinase Deficiency. Medicine, 95 (11), 3027. doi:10.1097/MD.0000000000003027 Peer Reviewed verified by ORBi |
| MALAISE, O., CHAUVEHEID, F., VON FRENCKELL, C., LEONARD, P., MOUTSCHEN, M., DEMONTY, J., & MALAISE, M. (September 2015). Newly diagnosed adult onset Still’s disease between 2002 and 2014: retrospective clinical biological and therapeutic characterization. Comparison with 1988 – 2001 data [Poster presentation]. Belgian congress of Rheumatology 2015. Peer reviewed |
| Vandereyken, M., Amand, M., Van Overmeire, E., Zurashvili, T., MOUTSCHEN, M., Gilles, C., Van Ginderachter, J., & Rahmouni, S. (June 2015). Genetic depletion of the dual specificity protein phosphatase DUSP3 promotes LLC Lung tumour metastasis [Paper presentation]. Europhosphatase 2015: Phosphorylation switches and cellular homeostasis, Turku, Finland. |
| Vandereyken, M., Amand, M., Van Overmeire, E., Zurashvili, T., MOUTSCHEN, M., Noël, A., Gilles, C., Van Ginderachter, J., & Rahmouni, S. (June 2015). Genetic depletion of the dual specificity protein phosphatase DUSP3 promotes LLC Lung tumour metastasis [Poster presentation]. Europhosphatase 2015: Phosphorylation switches and cellular homeostasis, Turku, Finland. |
 | Singh, P.* , Dejager, L.* , Amand, M.* , Theatre, E., Vandereyken, M., Zurashvili, T., Singh, M., Mack, M., Timmermans, S., Musumeci, L., Dejardin, E., Mustelin, T., Van Ginderachter, J. A., Moutschen, M., Oury, C., Libert, C., & Rahmouni, S. (15 May 2015). DUSP3 genetic deletion confers M2-like−macrophage-dependent tolerance to septic shock. Journal of Immunology, 194 (10), 4951-62. doi:10.4049/jimmunol.1402431 Peer Reviewed verified by ORBi* These authors have contributed equally to this work. |
 | Belche, J. L., Kang, T., Ketterer, F., Berrewaerts, M.-A., MOUTSCHEN, M., & Giet, D. (May 2015). L’infection par le VIH : une maladie chronique redéfinissant la collaboration entre généralistes et spécialistes. Obstacles et opportunités. Santé Publique: Revue Multidisciplinaire pour la Recherche et l'Action, 27 (3/2015), 373-381. doi:10.3917/spub.153.0373 Peer Reviewed verified by ORBi |
 | STERGIOPOULOU, T., Walsh, T. J., SEGHAYE, M.-C., Netea, M. G., Casanova, J.-L., Moutschen, M., & PICARD, C. (March 2015). Deficiency of Interleukin-1 Receptor-associated Kinase 4 Presenting as Fatal Pseudomonas aeruginosa Bacteremia in Two Siblings. Pediatric Infectious Disease Journal, 34 (3), 299-300. doi:10.1097/INF.0000000000000550 Peer Reviewed verified by ORBi |
 | Musumeci, L., Kuijpers, M., Gilio, K., Hego, A., Theatre, E., Maurissen, L., Vandereyken, M., Diogo, C., LECUT, C., Guilmain, W., Bobkova, E., Eble, J., Dahl, R., Drion, P., Rascon, J., Mostofi, Y., Yuan, H., Sergienko, E., Chung, T., ... Rahmouni, S.*. (17 February 2015). DUSP3 Phosphatase Deficiency or Inhibition Limit Platelet Activation and Arterial Thrombosis. Circulation, 131 (7), 656-68. doi:10.1161/CIRCULATIONAHA.114.010186 Peer Reviewed verified by ORBi* These authors have contributed equally to this work. |
 | Van Beckhoven, D., Florence, E., Ruelle, J., Deblonde, J., Verhofstede, C., Callens, S., Vancutsem, E., Lacor, P., Demeester, R., Goffard, J.-C., Sasse, A., De Wit, S., Vogelaers, D., Delforge, M.-L., Florence, E., Fransen, K., Goffard, J.-C., Hayette, M.-P., Lacor, P., ... Verhofstede, C. (2015). Good continuum of HIV care in Belgium despite weaknesses in retention and linkage to care among migrants. BMC Infectious Diseases, 15 (1). doi:10.1186/s12879-015-1230-3 Peer Reviewed verified by ORBi |
 | Bruls, S.* , Courtois, A.* , Nusgens, B., Defraigne, J.-O., Delvenne, P., Hustinx, R., Moutschen, M., & SAKALIHASAN, N. (2015). 18F-FDG PET/CT in the Management of Aortitis. Clinical Nuclear Medicine. doi:10.1097/RLU.0000000000001016 Peer Reviewed verified by ORBi* These authors have contributed equally to this work. |
 | Kouri, V., Khouri, R., Alemán, Y., Abrahantes, Y., Vercauteren, J., Pineda-Peña, A.-C., Theys, K., Megens, S., Moutschen, M., Pfeifer, N., Van Weyenbergh, J., Pérez, A. B., Pérez, J., Pérez, L., Van Laethem, K., & Vandamme, A.-M. (2015). CRF19_cpx is an Evolutionary fit HIV-1 Variant Strongly Associated With Rapid Progression to AIDS in Cuba. EBioMedicine, 2 (3), 244-254. doi:10.1016/j.ebiom.2015.01.015 Peer Reviewed verified by ORBi |
 | DARCIS, G., Kula, A., Bouchat, S., Fujinaga, K., Corazza, F., Ait-Ammar, A., Delacourt, N., Melard, A., Kabeya, K., Vanhulle, C., Van Driessche, B., GATOT, J.-S., Cherrier, T., Pianowski, L. F., Gama, L., Schwartz, C., Vila, J., Burny, A., Clumeck, N., ... Van Lint, C. (2015). An In-Depth Comparison of Latency-Reversing Agent Combinations in Various In Vitro and Ex Vivo HIV-1 Latency Models Identified Bryostatin-1+JQ1 and Ingenol-B+JQ1 to Potently Reactivate Viral Gene Expression. PLoS Pathogens, 11 (7), 1005063. doi:10.1371/journal.ppat.1005063 Peer Reviewed verified by ORBi |
 | Lantto, R., Nasi, A., Sammicheli, S., Amu, S., Fievez, V., Moutschen, M., Pensieroso, S., Hejdeman, B., Chiodi, F., & Rethi, B. (2015). Increased extrafollicular expression of the B-cell stimulatory molecule CD70 in HIV-1-infected individuals. AIDS, 29 (14), 1757-1766. doi:10.1097/QAD.0000000000000779 Peer Reviewed verified by ORBi |
 | FRIPPIAT, F., Musuamba, F. T., Seidel, L., Albert, A., DENOOZ, R., Charlier, C., Van Bambeke, F., Wallemacq, P., DESCY, J., LAMBERMONT, B., LAYIOS, N., DAMAS, P., & Moutschen, M. (12 September 2014). Modelled target attainment after meropenem infusion in patients with severe nosocomial pneumonia: the PROMESSE study. Journal of Antimicrobial Chemotherapy, 70, 207-216. doi:10.1093/jac/dku354 Peer Reviewed verified by ORBi |
 | STERGIOPOULOU, T., Walsh, T. J., SEGHAYE, M.-C., Netea, M. G., Casanova, J.-L., MOUTSCHEN, M., & Picard, C. (09 May 2014). Primary deficiency of interleukin-1 receptor-associated kinase (IRAK-4) presenting as fatal pseudomonas aeruginosa bacteremia in two siblings [Poster presentation]. 32nd Annual Meeting of the European Society for Paediatric Infectious Diseases, Dublin, Ireland. |
 | Singh, M., Singh, P., VAIRA, D., Torheim, E. A., Rahmouni, S., Tasken, K., & MOUTSCHEN, M. (February 2014). The RIAD peptidomimetic inhibits HIV-1 replication in humanized NSG mice. European Journal of Clinical Investigation, 44 (2), 146-152. doi:10.1111/eci.12200 Peer Reviewed verified by ORBi |
 | Amand, M., Erpicum, C., BAJOU, K., Cerignoli, F., Blacher, S., MARTIN, M., Dequiedt, F., Drion, P., Singh, P., Vandereyken, M., Musumeci, L., Moutschen, M., Gilles, C., Noël, A., & Rahmouni, S. (27 January 2014). DUSP3/VHR is a pro-angiogenic atypical dual-specificity phosphatase [Poster presentation]. GIGA Day 2014, Liège, Belgium. |
MILICEVIC, M., GROSCH, S., Krzesinski, J.-M., Moutschen, M., & BOVY, C. (22 January 2014). Un cas particulier d'amyloïdose AA [Paper presentation]. Confrontations anatomocliniques en pathologie rénale et vasculaire, Paris, France. |
DARCIS, G., Kula, A., Bouchat, S., Kabeya, K., Delacourt, N., Vanhulle, C., GATOT, J.-S., VAIRA, D., Burny, A., Clumeck, N., Rohr, O., MOUTSCHEN, M., Corrazza, F., Rouzioux, C., De Wit, S., & Van Lint, C. (2014). Synergistic activation of HIV-1 expression by compounds targeting the positive transcription elongation factor b (P-TEFb) and by inducers of the NF-kB signaling pathway [Paper presentation]. 20th AIDS international conference, Melbourne, Australia. |
 | LAYIOS, N., CANIVET, J.-L., Baron, F., Moutschen, M., & Hayette, M.-P. (2014). Mortierella wolfii-Associated Invasive Disease. Emerging Infectious Diseases, 20 (9), 1591-2. doi:10.3201/eid2009.140469 Peer Reviewed verified by ORBi |
 | Frippiat, F., Seidel, L., Denooz, R., DAMAS, P., Layios, N., & Moutschen, M. (2014). Pharmacokinetics of Extended vs Intermittent Intravenous Infusion of Meropenem in Critically Ill Patients Receiving Continuous Veno-Venous Haemofiltration. Open Forum Infectious Diseases. doi:10.1093/ofid/ofu052 Peer Reviewed verified by ORBi |
 | Megens, S., VAIRA, D., De Baets, G., Dekeersmaeker, N., Schrooten, Y., Li, G., Schymkowitz, J., Rousseau, F., Vandamme, A.-M., Moutschen, M., & Van Laethem, K. (2014). Horizontal gene transfer from human host to HIV-1 reverse transcriptase confers drug resistance and partly compensates for replication deficits. Virology, 456-457, 310-8. doi:10.1016/j.virol.2014.03.023 Peer Reviewed verified by ORBi |
 | Duray, A., Demoulin, S., Petermans, J., Moutschen, M., Saussez, S., Jerusalem, G., & Delvenne, P. (2014). Vieillissement et cancer: coincidence ou relation etiologique? Revue Médicale de Liège, 69 (5-6), 276-81. Peer reviewed |
 | Bonhomme, O., & Moutschen, M. (2014). Diagnostic et traitement des oedèmes angioneurotiques héréditaires: Illustration clinique et brève revue de la littérature. Revue Médicale de Liège, 69 (10), 541 - 548. Editorial Reviewed verified by ORBi |
 | Amand, M., Erpicum, C., BAJOU, K., Cerignoli, F., Blacher, S., Martin, M., Dequiedt, F., Drion, P., Singh, P., Zurashvili, T., Vandereyken, M., Musumeci, L., Mustelin, T., Moutschen, M., Gilles, C., Noël, A., & Rahmouni, S. (2014). DUSP3/VHR is a pro-angiogenic atypical dual-specificity phosphatase. Molecular Cancer. doi:10.1186/1476-4598-13-108 Peer Reviewed verified by ORBi |
 | Torres, A., Bonanni, P., Hryniewicz, W., Moutschen, M., Reinert, R. R., & Welte, T. (2014). Pneumococcal vaccination: what have we learnt so far and what can we expect in the future? European Journal of Clinical Microbiology and Infectious Diseases. doi:10.1007/s10096-014-2208-6 Peer Reviewed verified by ORBi |
 | Singh, M., Singh, P., VAIRA, D., Amand, M., Rahmouni, S., & Moutschen, M. (2014). Minocycline attenuates HIV-1 infection and suppresses chronic immune activation in humanized NOD/LtsZ-scidIL-2Rgamma(null) mice. Immunology, 142 (4), 562-72. doi:10.1111/imm.12246 Peer Reviewed verified by ORBi |
 | ESSER, N., L'Homme, L., DE ROOVER, A., KOHNEN, L., SCHEEN, A., MOUTSCHEN, M., Piette, J., Legrand-Poels, S., & PAQUOT, N. (November 2013). Obesity phenotype is related to NLRP3 inflammasome activity and immunological profile of visceral adipose tissue. Diabetologia, 56, 2487-2497. doi:10.1007/s00125-013-3023-9 Peer Reviewed verified by ORBi |
 | Adawaye, C. I., Erick, K., Ali, M. M., Bertin, T., VAIRA, D., & MOUTSCHEN, M. (September 2013). Use of Dried Blood Spot to Improve the Diagnosis and Management of HIV in Resource-Limited Settings. World Journal of AIDS, 3, 251-256. doi:10.4236/WJA.2013.33033 Peer reviewed |
 | LAYIOS, N., HAYETTE, M.-P., HUWART, A., JOSKIN, J., BLETARD, N., BARON, F., & MOUTSCHEN, M. (September 2013). First report of Mortierella wolfii causing human disease [Poster presentation]. 53rd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC). |
 | LAYIOS, N., HAYETTE, M.-P., HUWART, A., JOSKIN, J., BLETARD, N., BARON, F., & MOUTSCHEN, M. (September 2013). First report of Mortierella wolfii causing human disease [Paper presentation]. 53rd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC). |
 | Musumeci, L., Maurissen, L., Kuijpers, M. J., Senis, Y., MOUTSCHEN, M., Mustelin, T., Heemskerk, J. W., Oury, C., & Rahmouni, S. (02 July 2013). Genetic deletion of Vaccinia H1-related (VHR) phosphatase inhibits collagen-induced platelet activation and thrombus formation without affecting bleeding time in mice [Paper presentation]. XXIVth Congress of the ISTH, Amsterdam, Netherlands. |
| Esser, N., L'Homme, L., DE ROOVER, A., KOHNEN, L., SCHEEN, A., MOUTSCHEN, M., Piette, J., Legrand-Poels, S., & PAQUOT, N. (2013). Increased Inflammasome and Caspase-1 Activation in Visceral adipose tissue from Metabolically Unhealthy Obese compared to Metabolically Healthy Obese subjects. Diabetes, (62/suppl.1), 555. Peer Reviewed verified by ORBi |
 | Rahmouni, S., Singh, P., Dejager, L., Singh, M., Amand, M., Musumeci, L., Moutschen, M., Mustelin, T., & Libert, C. (2013). Dual-specificity phosphatase 3 knockout female mice are resistant to LPS and to polymicrobial induced septic shock in TNF dependent manner. Journal of Immunology. Peer Reviewed verified by ORBi |
 | Esser, N., L'Homme, L., DE ROOVER, A., KOHNEN, L., SCHEEN, A., Moutschen, M., Piette, J., Legrand-Poels, S., & PAQUOT, N. (March 2013). Différences d’activité de l’inflammasome NLRP3 entre sujets obèses avec et sans anomalies métaboliques. Diabetes and Metabolism, 39 (suppl 1), 102. Peer Reviewed verified by ORBi |
DARCIS, G., Kula, A., Bouchat, S., Kabeya, K., Delacourt, N., Vanhulle, C., GATOT, J.-S., VAIRA, D., Burny, A., Herbein, G., Clumeck, N., Rohr, O., MOUTSCHEN, M., Rouzioux, C., De Wit, S., & Van Lint, C. (2013). Synergistic activation of HIV-1 expression by compounds targeting the positive transcription elongation factor b (P-TEFb) and by inducers of the NF-B signaling pathway [Paper presentation]. First annual meeting Belgian Society for Virology. |
 | Esser, N., L'Homme, L., SCHEEN, A., MOUTSCHEN, M., Piette, J., PAQUOT, N., & Legrand, S. (January 2013). Differences in inflammasome activation between metabolically healthy and unhealthy obese individuals [Poster presentation]. Metabolic control of inflammation and immunity, Breckenridge, Colorado, United States. |
 | MAYAKI, Z., Dardenne, N., KAB0, R., Moutschen, M., Sondag, D., Albert, A., & GERARD, C. (2013). seroprevalence of infectious markers among blood donors in Niamey (Niger). Revue d'Épidémiologie et de Santé Publique, 61 (3), 233-240. doi:10.1016/j.respe.2012.12.018 Peer Reviewed verified by ORBi |
 | Pirotte, B., Rassenfosse, M., Collin, R., De Voeght, A., MOUTSCHEN, M., & CAVALIER, E. (2013). Rôle de la vitamine D dans l'infection par le VIH: revue des connaissances actuelles. Revue Médicale de Liège, 68 (1), 25-31. Peer reviewed |
DARCIS, G., Kula, A., Bouchat, S., Kabeya, K., Delacourt, N., Vanhulle, C., GATOT, J.-S., VAIRA, D., Burny, A., Herbein, G., Clumeck, N., Rohr, O., MOUTSCHEN, M., Rouzioux, C., De Wit, S., & Van Lint, C. (2013). Synergistic activation of HIV-1 expression by compounds targeting the positive transcription elongation factor b (P-TEFb) and by inducers of the NF-B signaling pathway [Paper presentation]. 14th European AIDS Conference (EACS), Brussels. |
 | Lubangi, M., & MOUTSCHEN, M. (2012). Perceptions de la pratique des essais cliniques sur le VIH/sida par les médecins prescripteurs des antirétroviraux agréés de Kinshasa (RD Congo). Bulletin de la Société de Pathologie Exotique. doi:10.1007/s13149-012-0263-8 Peer Reviewed verified by ORBi |
| Moutschen, M., FRIPPIAT, F., CHRISTIAENS, G., & ALLEPAERTS, S. (14 June 2012). HYGIENE ET PROBLEMES INFECTIEUX EN GERIATRIE [Paper presentation]. SOIREES DU MASTER COMPLEMENTAIRE EN GERIATRIE, CHENEE (LIEGE), Belgium. |
 | MOUTSCHEN, M. (2012). Gentetics, environment and determinants of autoimmune diseases. Revue Médicale de Liège, 67, 263-72. Peer reviewed |
 | Van Beckhoven, D., Buve, A., Ruelle, J., Seyler, L., Sasse, A., & MOUTSCHEN, M. (2012). A national cohort of HIV-infected patients in Belgium: design and main characteristics. Acta Clinica Belgica, 67 (5), 333-7. doi:10.2143/ACB.67.5.2062686 Peer Reviewed verified by ORBi |
 | Lopez-Herrera, G., Tampella, G., Pan-Hammarstrom, Q., Herholz, P., Trujillo-Vargas, C. M., Phadwal, K., Simon, A. K., Moutschen, M., Etzioni, A., Mory, A., Srugo, I., Melamed, D., Hultenby, K., Liu, C., Baronio, M., Vitali, M., Philippet, P., DIDEBERG, V., Aghamohammadi, A., ... Grimbacher, B. (2012). Deleterious mutations in LRBA are associated with a syndrome of immune deficiency and autoimmunity. American Journal of Human Genetics, 90 (6), 986-1001. doi:10.1016/j.ajhg.2012.04.015 Peer Reviewed verified by ORBi |
 | Singh, M., Singh, P., Gaudray, G., Musumeci, L., Thielen, C., VAIRA, D., Vandergeeten, C., Delacroix, L., Van Gulck, E., Vanham, G., de Leval, L., Rahmouni, S., & MOUTSCHEN, M. (2012). An improved protocol for efficient engraftment in NOD/LTSZ-SCIDIL-2Rgammanull mice allows HIV replication and development of anti-HIV immune responses. PLoS ONE, 7 (6), 38491. doi:10.1371/journal.pone.0038491 Peer Reviewed verified by ORBi |
 | Theys, K., Deforche, K., Vercauteren, J., Libin, P., van de Vijver, D. A., Albert, J., Asjo, B., Balotta, C., Bruckova, M., Camacho, R. J., Clotet, B., Coughlan, S., Grossman, Z., Hamouda, O., Horban, A., Korn, K., Kostrikis, L. G., Kucherer, C., Nielsen, C., ... MOUTSCHEN, M. (2012). Treatment-associated polymorphisms in protease are significantly associated with higher viral load and lower CD4 count in newly diagnosed drug-naive HIV-1 infected patients. Retrovirology, 9, 81. doi:10.1186/1742-4690-9-81 Peer Reviewed verified by ORBi |
 | Crook, D. W., Walker, A. S., Kean, Y., Weiss, K., Cornely, O. A., Miller, M. A., Esposito, R., Louie, T. J., Stoesser, N. E., Young, B. C., Angus, B. J., Gorbach, S. L., Peto, T. E. A., & MOUTSCHEN, M. (Other coll.). (2012). Fidaxomicin versus vancomycin for Clostridium difficile infection: meta-analysis of pivotal randomized controlled trials. Clinical Infectious Diseases, 55 Suppl 2, 93-103. doi:10.1093/cid/cis499 Peer Reviewed verified by ORBi |
| CAVALIER, E., MOUTSCHEN, M., & Brunel, E. (24 November 2011). Vitamine D et maladies infectieuses [Paper presentation]. Formations Continues en Biologie Clinique, Liège, Belgium. |
 | Singh, M., Singh, P., VAIRA, D., Tasken, K., Rahmouni, S., & Moutschen, M. (03 October 2011). Humanized mice as a useful model to study HIV-1 induced immune activation, its mechanisms and potential therapeutic approaches. Retrovirology, 8, 62. Peer Reviewed verified by ORBi |
 | Herfs, M., Hubert, P., Moutschen, M., & Delvenne, P. (07 January 2011). Mucosal junctions: open doors to HPV and HIV infections? Trends in Microbiology, 19 (3), 114-120. doi:10.1016/j.tim.2010.12.006 Peer Reviewed verified by ORBi |
 | DOUPAGNE, G., Toukouki, A., & Moutschen, M. (2011). Des interactions complexes entre les origines du VIH et sa pandemie, les activites coloniales en Afrique et la medecine coloniale Belge au Congo. Revue Médicale de Liège, 66 (9), 478-84. Peer reviewed |
 | Mosenden, R.* , Singh, P.* , Cornez, I., Heglind, M., Ruppelt, A., MOUTSCHEN, M., Enerbäck, S., Rahmouni, S., & Tasken, K. (2011). Mice with Disrupted Type I Protein Kinase A Anchoring in T Cells Resist Retrovirus-Induced Immunodeficiency. Journal of Immunology, 186 (9), 5119-30. doi:10.4049/jimmunol.1100003 Peer Reviewed verified by ORBi* These authors have contributed equally to this work. |
 | Vandekerckhove, L., Verhofstede, C., Demecheleer, E., De Wit, S., Florence, E., Fransen, K., Moutschen, M., Mostmans, W., Kabeya, K., Mackie, N., Plum, J., VAIRA, D., Van Baelen, K., Vandenbroucke, I., Van Eygen, V., Van Marck, H., Vogelaers, D., Geretti, A. M., & Stuyver, L. J. (2011). Comparison of phenotypic and genotypic tropism determination in triple-class-experienced HIV patients eligible for maraviroc treatment. Journal of Antimicrobial Chemotherapy, 66 (2), 265-72. doi:10.1093/jac/dkq458 |
 | Moutschen, P., Bourhaba, M., FRIPPIAT, F., GIOT, J.-B., MEURIS, C., Leonard, P., & Moutschen, M. (2011). A pauci-symptomatic case of documented Hantavirus (Puumala) infection in a patient under anti-TNF treatment. Journal of Clinical Virology, 50 (3), 247-8. doi:10.1016/j.jcv.2010.11.016 Peer Reviewed verified by ORBi |
 | FRIPPIAT, F., & Moutschen, M. (2011). Syphilis treatment in the human immunodeficiency virus-infected patient: follow the guidelines. Clinical Infectious Diseases, 53 (8), 845. doi:10.1093/cid/cir513 Peer Reviewed verified by ORBi |
 | Rahier, J.-F., Moutschen, M., Van Gompel, A., Van Ranst, M., Louis, E., Segaert, S., Masson, P., & De Keyser, F. (2010). Vaccinations in patients with immune-mediated inflammatory diseases. Rheumatology, 49 (10), 1815-27. doi:10.1093/rheumatology/keq183 Peer Reviewed verified by ORBi |
 | Maquet, D., Croisier, J.-L., Dupont, C., Moutschen, M., Ansseau, M., Zeevaert, B., & Crielaard, J.-M. (2010). Fibromyalgia and related conditions: Electromyogram profile during isometric muscle contraction. Joint Bone Spine, 77, 264–267. doi:10.1016/j.jbspin.2010.02.003 Peer Reviewed verified by ORBi |
 | Maquet, D., Croisier, J.-L., Dupont, C., Moutschen, M., Ansseau, M., Zeevaert, B., & Crielaard, J.-M. (2010). Fibromyalgie et affections voisines : analyse du comportement électromyographique au cours d’un effort musculaire isométrique. Revue du Rhumatisme, 77, 296-300. doi:10.1016/j.rhum.2009.10.026 Peer Reviewed verified by ORBi |
 | Geenen, V., Mottet, M., Dardenne, O., Kermani, H., Martens, H., François, J.-M., Galleni, M., Hober, D., Rahmouni, S., & Moutschen, M. (2010). Thymic self-antigens for the design of a negative/tolerogenic self-vaccination against type 1 diabetes. Current Opinion in Pharmacology, 10, 461-472. doi:10.1016/j.coph.2010.04.005 Peer Reviewed verified by ORBi |
 | Vandenbroucke, I., Van Marck, H., Mostmans, W., Van Eygen, V., Rondelez, E., Thys, K., Van Baelen, K., Fransen, K., Vaira, D., Kabeya, K., De Wit, S., Florence, E., Moutschen, M., Vandekerckhove, L., Verhofstede, C., & Stuyver, L. J. (2010). HIV-1 V3 envelope deep sequencing for clinical plasma specimens failing in phenotypic tropism assays. AIDS Research and Therapy, 7, 4. doi:10.1186/1742-6405-7-4 Peer Reviewed verified by ORBi |
 | Moyle, G., Moutschen, M., Martinez, E., Domingo, P., Guaraldi, G., Raffi, F., Behrens, G., & Reiss, P. (2010). Epidemiology, assessment, and management of excess abdominal fat in persons with HIV infection. AIDS Reviews, 12 (1), 3-14. Peer Reviewed verified by ORBi |
 | Steigbigel, R. T., Cooper, D. A., Teppler, H., Eron, J. J., Gatell, J. M., Kumar, P. N., Rockstroh, J. K., Schechter, M., Katlama, C., Markowitz, M., Yeni, P., Loutfy, M. R., Lazzarin, A., Lennox, J. L., Clotet, B., Zhao, J., Wan, H., Rhodes, R. R., Strohmaier, K. M., ... Moutschen, M. (Other coll.). (2010). Long-term efficacy and safety of Raltegravir combined with optimized background therapy in treatment-experienced patients with drug-resistant HIV infection: week 96 results of the BENCHMRK 1 and 2 phase iii trials. Clinical Infectious Diseases, 50 (4), 605-12. doi:10.1086/650002 Peer Reviewed verified by ORBi |
 | Wu, S.* , Vossius, S.* , Rahmouni, S.* , Miletic, A. V., Vang, T., Vazquez-Rodriguez, J., Cerignoli, F., Arimura, Y., Williams, S., Hayes, T., Moutschen, M., Vasile, S., Pellecchia, M., Mustelin, T., & Tautz, L. (12 November 2009). Multidentate small-molecule inhibitors of vaccinia H1-related (VHR) phosphatase decrease proliferation of cervix cancer cells. Journal of Medicinal Chemistry, 52 (21), 6716-23. doi:10.1021/jm901016k Peer Reviewed verified by ORBi* These authors have contributed equally to this work. |
 | Mukeba, D., Chandrikakumari, K., Giot, J.-B., Leonard, P., Meuris, C., Frippiat, F., & Moutschen, M. (2009). Autoimmune angioneurotic edema in a patient with Helicobacter pylori infection. Helicobacter, 14 (1), 9-11. doi:10.1111/j.1523-5378.2009.00651.x Peer Reviewed verified by ORBi |
 | Rodger, A. J., Fox, Z., Lundgren, J. D., Kuller, L. H., Boesecke, C., Gey, D., Skoutelis, A., Goetz, M. B., Phillips, A. N., & Moutschen, M. (Other coll.). (2009). Activation and coagulation biomarkers are independent predictors of the development of opportunistic disease in patients with HIV infection. Journal of Infectious Diseases, 200 (6), 973-83. doi:10.1086/605447 Peer Reviewed verified by ORBi |
 | Frippiat, F., Chandrikakumari, K., & Moutschen, M. (2009). Gentamicin in infective endocarditis: how to use it? Clinical Infectious Diseases, 49 (2), 320-1; author reply 321. doi:10.1086/600063 Peer Reviewed verified by ORBi |
 | Katlama, C., Haubrich, R., Lalezari, J., Lazzarin, A., Madruga, J. V., Molina, J.-M., Schechter, M., Peeters, M., Picchio, G., Vingerhoets, J., Woodfall, B., De Smedt, G., & Moutschen, M. (Other coll.). (2009). Efficacy and safety of etravirine in treatment-experienced, HIV-1 patients: pooled 48 week analysis of two randomized, controlled trials. AIDS, 23 (17), 2289-300. doi:10.1097/QAD.0b013e3283316a5e Peer Reviewed verified by ORBi |
 | Reuse, S., Calao, M., Kabeya, K., Guiguen, A., GATOT, J.-S., Quivy, V., Vanhulle, C., Lamine, A., Vaira, D., Demonte, D., Martinelli, V., Veithen, E., Cherrier, T., Avettand, V., Poutrel, S., Piette, J., de Launoit, Y., Moutschen, M., Burny, A., ... Van Lint, C. (2009). Synergistic activation of HIV-1 expression by deacetylase inhibitors and prostratin: implications for treatment of latent infection. PLoS ONE, 4 (6), 6093. doi:10.1371/journal.pone.0006093 Peer Reviewed verified by ORBi |
 | Scheen, A., & Moutschen, M. (2009). Les anticorps monoclonaux en thérapeutique. Revue Médicale de Liège, 64 (5-6), 233-6. Peer reviewed |
 | Morrhaye, G., Kermani, H., Legros, J.-J., Baron, F., Beguin, Y., Moutschen, M., Cheynier, R., Martens, H., & Geenen, V. (2009). Impact of growth hormone (GH) deficiency and GH replacement upon thymus function in adult patients. PLoS ONE, 4 (5), 5668. doi:10.1371/journal.pone.0005668 Peer Reviewed verified by ORBi |
 | Moutschen, M., & Scheen, A. (2009). Bases immunologiques a la comprehension du concept d'anticorps monoclonal. Revue Médicale de Liège, 64 (5-6), 237-43. Peer reviewed |
 | Garcia, M. V., Mukeba-Tshialala, D., Vaira, D., & Moutschen, M. (2009). Triom une: la tritherapie du pauvre ? Revue Médicale de Liège, 64 (1), 32-6. Peer reviewed |
 | Mocroft, A., Wyatt, C., Szczech, L., Neuhaus, J., El-Sadr, W., Tracy, R., Kuller, L., Shlipak, M., Angus, B., Klinker, H., Ross, M., & Moutschen, M. (Other coll.). (2009). Interruption of antiretroviral therapy is associated with increased plasma cystatin C. AIDS, 23 (1), 71-82. doi:10.1097/QAD.0b013e32831cc129 Peer Reviewed verified by ORBi |
 | Hafraoui, K., Moutschen, M., Smet, J., Mascart, F., Schaaf-Lafontaine, N., & Fillet, G. (2009). Selective defect of anti-pneumococcal IgG in a patient with persistent polyclonal B cell lymphocytosis. European Journal of Internal Medicine, 20 (3), 62-5. doi:10.1016/j.ejim.2008.08.005 Peer Reviewed verified by ORBi |
 | Fatkenheuer, G., Nelson, M., Lazzarin, A., Konourina, I., Hoepelman, A. I. M., Lampiris, H., Hirschel, B., Tebas, P., Raffi, F., Trottier, B., Bellos, N., Saag, M., Cooper, D. A., Westby, M., Tawadrous, M., Sullivan, J. F., Ridgway, C., Dunne, M. W., Felstead, S., ... Moutschen, M. (Other coll.). (2008). Subgroup analyses of maraviroc in previously treated R5 HIV-1 infection. New England Journal of Medicine, 359 (14), 1442-55. doi:10.1056/NEJMoa0803154 Peer Reviewed verified by ORBi |
 | Gulick, R. M., Lalezari, J., Goodrich, J., Clumeck, N., DeJesus, E., Horban, A., Nadler, J., Clotet, B., Karlsson, A., Wohlfeiler, M., Montana, J. B., McHale, M., Sullivan, J., Ridgway, C., Felstead, S., Dunne, M. W., van der Ryst, E., Mayer, H., & Moutschen, M. (Other coll.). (2008). Maraviroc for previously treated patients with R5 HIV-1 infection. New England Journal of Medicine, 359 (14), 1429-41. doi:10.1056/NEJMoa0803152 Peer Reviewed verified by ORBi |
 | Steigbigel, R. T., Cooper, D. A., Kumar, P. N., Eron, J. E., Schechter, M., Markowitz, M., Loutfy, M. R., Lennox, J. L., Gatell, J. M., Rockstroh, J. K., Katlama, C., Yeni, P., Lazzarin, A., Clotet, B., Zhao, J., Chen, J., Ryan, D. M., Rhodes, R. R., Killar, J. A., ... Moutschen, M. (Other coll.). (2008). Raltegravir with optimized background therapy for resistant HIV-1 infection. New England Journal of Medicine, 359 (4), 339-54. doi:10.1056/NEJMoa0708975 Peer Reviewed verified by ORBi |
 | Nkoghe, D., Moutschen, M., & Demonty, J. (2008). Lesions cerebrales demyelinisantes decouvertes chez un patient immunocompetent VIH-1+. Médecine et Maladies Infectieuses, 38 (9), 500-3. doi:10.1016/j.medmal.2008.06.010 Peer Reviewed verified by ORBi |
 | Fox, Z., Phillips, A., Cohen, C., Neuhaus, J., Baxter, J., Emery, S., Hirschel, B., Hullsiek, K. H., Stephan, C., Lundgren, J., & Moutschen, M. (Other coll.). (2008). Viral resuppression and detection of drug resistance following interruption of a suppressive non-nucleoside reverse transcriptase inhibitor-based regimen. AIDS, 22 (17), 2279-89. doi:10.1097/QAD.0b013e328311d16f Peer Reviewed verified by ORBi |
 | Bethlen, S., Chandrikakumari, K., de Leval, L., GIOT, J.-B., Mukeba, D., Leonard, P., Frippiat, F., Meuris, C., Delwaide, J., & Moutschen, M. (2008). Chronic hepatitis C infection in a patient with bone marrow hypoplasia. World Journal of Gastroenterology, 14 (26), 4238-40. doi:10.3748/wjg.14.4238 Peer Reviewed verified by ORBi |
 | Henkens, R., Delvenne, P., Arafa, M., Moutschen, M., Zeddou, M., Tautz, L., Boniver, J., Mustelin, T., & Rahmouni, S. (2008). Cervix carcinoma is associated with an up-regulation and nuclear localization of the dual-specificity protein phosphatase VHR. BMC Cancer, 8, 147. doi:10.1186/1471-2407-8-147 Peer Reviewed verified by ORBi |
 | Vercauteren, J., Derdelinckx, I., Sasse, A., Bogaert, M., Ceunen, H., De Roo, A., De Wit, S., Deforche, K., Echahidi, F., Fransen, K., Goffard, J.-C., Goubau, P., Goudeseune, E., Yombi, J.-C., Lacor, P., Liesnard, C., Moutschen, M., Piérard, D., Rens, R., ... van Laethem, K. (2008). Prevalence and epidemiology of HIV type 1 drug resistance among newly diagnosed therapy-naive patients in Belgium from 2003 to 2006. AIDS Research and Human Retroviruses, 24 (3), 355-62. doi:10.1089/aid.2007.0212 Peer Reviewed verified by ORBi |
 | Chandrikakumari, K., Giot, J.-B., de Leval, L., Creemers, E., Leonard, P., Mukeba, D., Moutschen, M., & Frippiat, F. (2008). Report of a case of Streptococcus agalactiae mycotic aneurysm and review of the literature. International Journal of Surgical Pathology, 16 (3), 314-9. doi:10.1177/1066896907310304 Peer Reviewed verified by ORBi |
 | El-Sadr, W. M., Grund, B., Neuhaus, J., Babiker, A., Cohen, C. J., Darbyshire, J., Emery, S., Lundgren, J. D., Phillips, A., Neaton, J. D., & Moutschen, M. (Other coll.). (2008). Risk for opportunistic disease and death after reinitiating continuous antiretroviral therapy in patients with HIV previously receiving episodic therapy: a randomized trial. Annals of Internal Medicine, 149 (5), 289-99. doi:10.7326/0003-4819-149-5-200809020-00003 Peer Reviewed verified by ORBi |
 | Mafuko Nsabimana, J.-M., Moutschen, M., Thiry, E., & Meurens, F. (2008). Infection humaine par le virus B du singe en Afrique. Santé: Cahiers d'Études et de Recherches Francophones, 18 (1), 3-8. doi:10.1684/san.2008.0101 Peer Reviewed verified by ORBi |
 | Emery, S., Neuhaus, J. A., Phillips, A. N., Babiker, A., Cohen, C. J., Gatell, J. M., Girard, P.-M., Grund, B., Law, M., Losso, M. H., Palfreeman, A., Wood, R., & Moutschen, M. (2008). Major clinical outcomes in antiretroviral therapy (ART)-naive participants and in those not receiving ART at baseline in the SMART study. Journal of Infectious Diseases, 197 (8), 1133-44. doi:10.1086/586713 Peer Reviewed verified by ORBi |
 | Lundgren, J. D., Babiker, A., El-Sadr, W., Emery, S., Grund, B., Neaton, J. D., Neuhaus, J., Phillips, A. N., & Moutschen, M. (Other coll.). (2008). Inferior clinical outcome of the CD4+ cell count-guided antiretroviral treatment interruption strategy in the SMART study: role of CD4+ Cell counts and HIV RNA levels during follow-up. Journal of Infectious Diseases, 197 (8), 1145-55. doi:10.1086/529523 Peer Reviewed verified by ORBi |
 | Frippiat, F., Chandrikakumari, K., & Moutschen, M. (2008). Decline of antibiotic use in primary care. The Lancet Infectious Diseases, 8 (5), 272; author reply 273. doi:10.1016/S1473-3099(08)70075-6 Peer Reviewed verified by ORBi |
 | Cooper, D. A., Steigbigel, R. T., Gatell, J. M., Rockstroh, J. K., Katlama, C., Yeni, P., Lazzarin, A., Clotet, B., Kumar, P. N., Eron, J. E., Schechter, M., Markowitz, M., Loutfy, M. R., Lennox, J. L., Zhao, J., Chen, J., Ryan, D. M., Rhodes, R. R., Killar, J. A., ... Moutschen, M. (2008). Subgroup and resistance analyses of raltegravir for resistant HIV-1 infection. New England Journal of Medicine, 359 (4), 355-65. doi:10.1056/NEJMoa0708978 Peer Reviewed verified by ORBi |
 | Nayjib, B., Zeddou, M., Drion, P., Boniver, J., Tasken, K., Rahmouni, S., & Moutschen, M. (2008). In vivo administration of a PKA type I inhibitor (Rp-8-Br-cAMPS) restores T-cell responses in retrovirus-infected mice. Open Immunology Journal, 1, 20-24. doi:10.2174/1874226200801010020 Peer reviewed |
| Frippiat, F., GIOT, J.-B., Chandrikakumari, K., Leonard, P., Meuris, C., & Moutschen, M. (2008). Syphilis en 2008: controverses et attitudes pratiques. Revue Médicale Suisse, 4 (168), 1823-7. Peer Reviewed verified by ORBi |
 | Sokal, E. M., Hoppenbrouwers, K., Vandermeulen, C., Moutschen, M., Leonard, P., Moreels, A., Haumont, M., Bollen, A., Smets, F., & Denis, M. (15 December 2007). Recombinant gp350 vaccine for infectious mononucleosis: A phase 2, randomized, double-blind, placebo-controlled trial to evaluate the safety, immunogenicity, and efficacy of an Epstein-Barr virus vaccine in healthy young adults. Journal of Infectious Diseases, 196 (12), 1749-1753. doi:10.1086/523813 Peer Reviewed verified by ORBi |
 | Uurlings, F., & Moutschen, M. (November 2007). Patients infectes par le VIH. Et syndrome lipodystrophique. Revue Médicale de Liège, 62 (11), 669-74. Peer reviewed |
 | Mayasi, N., Chandrikakumari, K., Mukeba, D., GIOT, J.-B., Leonard, P., Hayette, M.-P., Moutschen, M., & Frippiat, F. (01 September 2007). A Patient with Hiv Infection, Cough, Asthenia, and Fever. Clinical Infectious Diseases, 45 (5), 662-3, 559-600. doi:10.1086/520656 Peer Reviewed verified by ORBi |
 | Moutschen, M., Leonard, P., Sokal, E. M., Smets, F., Haumont, M., Mazzu, P., Bollen, A., Denamur, F., Peeters, P., Dubin, G., & Denis, M. (11 June 2007). Phase I/II studies to evaluate safety and immunogenicity of a recombinant gp350 Epstein-Barr virus vaccine in healthy adults. Vaccine, 25 (24), 4697-4705. doi:10.1016/j.vaccine.2007.04.008 Peer Reviewed verified by ORBi |
| Frippiat, F., Waleffe, A., Soyeur, D., Leonard, P., GIOT, J.-B., & Moutschen, M. (June 2007). Uncomplicated left-sided infective endocarditis due to Escherichia coli, successfully treated with oral levofloxacin. Clinical Research in Cardiology, 96 (6), 401. Peer Reviewed verified by ORBi |
 | Chandrika, K., Dellot, P., Frippiat, F., Giot, J.-B., Leonard, P., Marée, R., Mayasi, N., Meuris, C., Mukeba Tshialala, D., Rahmouni, S., Uurlings, F., Vaira, D., Wehenkel, L., Demonty, J., & Moutschen, M. (2007). Nouvelles approches dans la prise en charge de l'infection a VIH. Revue Médicale de Liège, 62 Spec No, 47-50. Peer reviewed |
 | GIOT, J.-B., Mukeba Tshialala, D., Mayasi Ngongo, N., Frippiat, F., Leonard, P., & Moutschen, M. (2007). Avancees therapeutiques en pathologie infectieuse au cours de la derniere decennie. Revue Médicale de Liège, 62 (5-6, May-Jun), 377-83. Peer reviewed |
 | Vandergeeten, C., Quivy, V., Moutschen, M., Van Lint, C., Piette, J., & Legrand-Poels, S. (2007). HIV-1 protease inhibitors do not interfere with provirus transcription and host cell apoptosis induced by combined treatment TNF-alpha plus TSA. Biochemical Pharmacology, 73 (11), 1738-1748. doi:10.1016/j.bcp.2007.02.011 Peer Reviewed verified by ORBi |
 | Castermans, E., Morrhaye, G., Marchand, S., Martens, H., Moutschen, M., Geenen, V., Beguin, Y., & Baron, F. (2007). Evaluation de la thymopoiese: applications cliniques. Revue Médicale de Liège, 62 (12), 725-9. Peer reviewed |
 | Castermans, E., Morrhaye, G., Marchand, S., Martens, H., Moutschen, M., Baron, F., Beguin, Y., & Geenen, V. (2007). Evaluation clinique de la fonction du thymus. Revue Médicale de Liège, 62 (11), 675-8. Peer reviewed |
 | Zeddou, M., Rahmouni, S., Vandamme, A., Jacobs, N., Frippiat, F., Leonard, P., SCHAAF-LAFONTAINE, N., Vaira, D., Boniver, J., & Moutschen, M. (2007). Downregulation of CD94/NKG2A inhibitory receptors on CD8+ T cells in HIV infection is more pronounced in subjects with detected viral load than in their aviraemic counterparts. Retrovirology, 4, 72. doi:10.1186/1742-4690-4-72 Peer Reviewed verified by ORBi |
 | Rahmouni, S., Cerignoli, F., Alonso, A., Tsutji, T., Henkens, R., Zhu, C., Louis-dit-Sully, C., Moutschen, M., Jiang, W., & Mustelin, T. (May 2006). Loss of the VHR dual-specific phosphatase causes cell-cycle arrest and senescence. Nature Cell Biology, 8 (5), 524-U178. doi:10.1038/ncb1398 Peer Reviewed verified by ORBi |
 | Zeddou, M., Boniver, J., Moutschen, M., & Rahmouni, S. (February 2006). Prostanglandin E2 induces the expression of functional inhibitory CD94/NKG2A receptors in human CD8+ T lymphocytes by a cAMP-dependent protein kinase A type I pathway [Paper presentation]. Keystone Symposia - Innate Immunity, Banff, Canada. |
 | Zeddou, M., Rahmouni, S., VANDAMME, A., Schaaf-Lafontaine, N., & Moutschen, M. (2006). HIV viraemic patients downregulate CD94/NKG2A inhibitory receptors on NK as well as CD8 T cells in comparison with aviraemic counterparts [Poster presentation]. AIDS 2006 - XVI International AIDS Conference. |
 | Collette, G., Bourhaba, M., & Moutschen, M. (2006). Doit-on encore recommander le vaccin BCG? Revue Médicale de Liège, 61 (5-6, May-Jun), 430-2. Peer reviewed |
 | Bourhaba, M., GIOT, J.-B., Tshialala, D. M., Leonard, P., Frippiat, F., & Moutschen, M. (2006). L'Hantavirose fait encore parler d'elle. Revue Médicale de Liège, 61 (5-6, May-Jun), 322-8. Peer reviewed |
 | Rahmouni, S., Vang, T., Alonso, A., Williams, S., van Stipdonk, M., Soncini, C., Moutschen, M., Schoenberger, S. P., & Mustelin, T. (March 2005). Removal of C-terminal Src kinase from the immune synapse by a new binding protein. Molecular and Cellular Biology, 25 (6), 2227-2241. doi:10.1128/MCB.25.6.2227-2241.2005 Peer Reviewed verified by ORBi |
 | Zeddou, M., Greimers, R., de Valensart, N., Nayjib, B., Tasken, K., Boniver, J., Moutschen, M., & Rahmouni, S. (2005). Prostaglandin E2 induces the expression of functional inhibitory CD94/NKG2A receptors in human CD8+ T lymphocytes by a cAMP-dependent protein kinase A type I pathway. Biochemical Pharmacology, 70 (5), 714-24. doi:10.1016/j.bcp.2005.05.015 Peer Reviewed verified by ORBi |
 | Moutschen, M. (2005). Anomalies des cellules de l'immunite naturelle et risque infectieux chez le patient diabetique. Revue Médicale de Liège, 60 (5-6, May-Jun), 541-4. Peer reviewed |
 | Rahmouni, S., Aandahl, E. M., Nayjib, B., Zeddou, M., Giannini, S., Verlaet, M., Greimers, R., Boniver, J., Tasken, K., & Moutschen, M. (15 December 2004). Cyclo-oxygenase type 2-dependent prostaglandin E-2 secretion is involved in retrovirus-induced T-cell dysfunction in mice. Biochemical Journal, 384 (Pt 3), 469-476. doi:10.1042/BJ20031859 Peer Reviewed verified by ORBi |
 | Derdelinckx, I., Van Laethem, K., Maes, B., Schrooten, Y., De Wit, S. P., Florence, E., Fransen, K., Ribas, S. G., Marissens, D., Moutschen, M., Vaira, D., Zissis, G., Van Ranst, M., Van Wijngaerden, E., & Vandamme, A.-M. (15 December 2004). Current levels of drug resistance among therapy-naive HIV-infected patients have significant impact on treatment response. Journal of Acquired Immune Deficiency Syndromes, 37 (5), 1664-1666. doi:10.1097/00126334-200412150-00022 Peer Reviewed verified by ORBi |
 | tasken, K., MOUTSCHEN, M., Rahmouni, S., Aandahl, E. M., Aukurst, P., Froland, S., Johansson, C., Hansson, V., & Klaveness, J. (29 April 2004). Use of COX-2 inhibitors for preventing immunodeficiency. |
 | Elira Dokekias, A., Moutschen, M., Purhuence, M. F., Malanda, F., & Moyikoua, A. (2004). Myelome multiple et infection a VIH/SIDA : a propos de trois observations. Revue Médicale de Liège, 59 (2), 95-7. Peer reviewed |
 | Derdelinckx, I., Van Laethem, K., Maes, B., Schrooten, Y., De Schouwer, K., De Wit, S., Fransen, K., Garcia Ribas, S., Moutschen, M., Vaira, D., Zissis, G., Van Ranst, M., Van Wijngaerden, E., & Vandamme, A.-M. (28 November 2003). Performance of the VERSANT (R) HIV-1 Resistance Assays (LiPA) for detecting drug resistance in therapy-naive patients infected with different HIV-1 subtypes. FEMS Immunology and Medical Microbiology, 39 (2), 119-124. doi:10.1016/S0928-8244(03)00240-2 Peer Reviewed verified by ORBi |
 | Leonard, P., Moutschen, M., & Demonty, J. (June 2003). Prevention du paludisme chez l'adulte. Revue Médicale de Liège, 58 (6), 382-7. Peer reviewed |
 | Maquet, D., Croisier, J.-L., Moutschen, M., & Crielaard, J.-M. (March 2003). Isokinetic evaluation of muscular function in patients with chronic pain and fatigability. Isokinetics and Exercise Science, 11 (1), 73-74. Peer Reviewed verified by ORBi |
 | GIOT, J.-B., Franchimont, N., & Moutschen, M. (March 2003). Anomalies du metabolisme osseux chez les patients infectes par le HIV et traites par tritherapie. Revue Médicale de Liège, 58 (3), 155-63. Peer reviewed |
 | Geenen, V., Poulin, J. F., Dion, M. L., Martens, H., Castermans, E., Hansenne, I., Moutschen, M., Sekaly, R. P., & Cheynier, R. (2003). Quantification of T cell receptor rearrangement excision circles to estimate thymic function: an important new tool for endocrine-immune physiology. Journal of Endocrinology, 176 (3), 305-311. doi:10.1677/joe.0.1760305 Peer Reviewed verified by ORBi |
TASKÉN, K., Moutschen, M., Rahmouni, S., Aandahl, E. M., AUKRUST, P., FRØLAND, S. S., JOHANSSON, C. C., HANSSON, V., & KLAVENESS, J. (31 January 2002). USE OF COX-2 INHIBITORS FOR PREVENTING IMMUNODEFICIENCY. |
 | Debruyn, X., Nkoghe, D., Leonard, P., Moutschen, M., & Demonty, J. (January 2002). Les anomalies morphologiques et metaboliques liees aux traitements antiretroviraux. Revue Médicale de Liège, 57 (1), 23-8. Peer reviewed |
 | Delbecque, K., Radermecker, M., Leonard, P., Moutschen, M., Hermans, G., Boniver, J., & de Leval, L. (2002). L'image du mois. Malacoplasie pulmonaire a Rhodococcus equi chez un patient atteint du SIDA. Revue Médicale de Liège, 57 (11), 685-7. Peer reviewed |
 | Geenen, V., PERRIER d'HAUTERIVE, S., Puit, M., Hazout, A., Goffin, F., Frankenne, F., Moutschen, M., & Foidart, J.-M. (2002). Autoimmunity and pregnancy: Theory and practice. Acta Clinica Belgica, 57 (6), 317-324. doi:10.1179/acb.2002.059 Peer Reviewed verified by ORBi |
 | Derdelinckx, I., Van Laethem, K., Maes, B., Schrooten, Y., Dewit, S., Florence, E., Fransen, K., Ribas, S. G., Marissens, D., Moutschen, M., Van Wijngaerden, E., Vaira, D., Zissis, G., Van Ranst, M., & Vandamme, A.-M. (2002). Drug resistance among therapy-naive HIV-infected patients studied by sequencing and VERSANT (TM) HIV-1 resistance assays (LiPA) has limited impact on treatment response. Antiviral Therapy, 7 (Suppl. 1), 181. Peer Reviewed verified by ORBi |
 | Blaise, P., Clevenbergh, P., Vaira, D., Moutschen, M., & Dellamonica, P. (2002). HIV resistance to antiretroviral drugs: Mechanisms, genotypic and phenotypic resistance testing in clinical practice. Acta Clinica Belgica, 57 (4, Jul-Aug), 191-201. doi:10.1179/acb.2002.041 Peer Reviewed verified by ORBi |
 | Nkoghe, D., Demonty, J., Léonard, P., Nnegue, S., Moutschen, M., & Kaye, O. (2002). La maladie de Still de l'adulte. Revue Médicale de Liège, 57 (4), 213 - 219. Editorial Reviewed verified by ORBi |
Leonard, P., Nkoghe, D., Moutschen, M., & Demonty, J. (November 2001). Pharma-clinics comment je traite ... une infection par le VIH. IV. Les inhibiteurs de protease. Revue Médicale de Liège, 56 (11), 739-44. Peer reviewed |
 | Rahmouni, S., Aandahl, E. M., Trebak, M., Boniver, J., Tasken, K., & Moutschen, M. (2001). Increased Camp Levels and Protein Kinase (Pka) Type I Activation in Cd4+ T Cells and B Cells Contribute to Retrovirus-Induced Immunodeficiency of Mice (Maids): A Useful in Vivo Model for Drug Testing. FASEB Journal, 15 (8), 1466-1468. doi:10.1096/fj.00-0813fje Peer Reviewed verified by ORBi |
Nkoghe, D., Kola, L., Leonard, P., Demonty, J., & Moutschen, M. (July 2000). Hydroxyuree et infection par le VIH. Revue Médicale de Liège, 55 (7), 721-4. Peer reviewed |
Lechanteur, C., Moutschen, M., Princen, F., Lopez, M.-J., Franzen, E., Gielen, J., Bours, V., & Merville, M.-P. (May 2000). Antitumoral Vaccination with Granulocyte-Macrophage Colony-Stimulating Factor or Interleukin-12-Expressing Dhd/K12 Colon Adenocarcinoma Cells. Cancer Gene Therapy, 7 (5), 676-82. doi:10.1038/sj.cgt.7700152 Peer Reviewed verified by ORBi |
Moutschen, M. (2000). Anomalies fonctionnelles des lymphocytes T dans un modèle murin d'infection rétrovirale [Post doctoral thesis, ULiège - Université de Liège]. ORBi-University of Liège. https://orbi.uliege.be/handle/2268/76279 |
 | Baudoux, E., Blaffart, F., Bouffioux, C., Caprasse, M., Courtois, F., Cremasco, M.-R., De Pasqual, E., Fassotte, M.-F., Gillet, P., Lamy, M., Larbuisson, R., Lemaire, R., Merciny, M., Moutschen, M., Radermecker, M., Remy, B., & Sondag, D. (2000). La commission d'hemovigilance du CHU. Revue Médicale de Liège, 55 (9), 878-80. Peer reviewed |
de Leval, L., Debrus, S., Lane, P., Boniver, J., & Moutschen, M. (December 1999). Mice Transgenic for a Soluble Form of Murine Cytotoxic T Lymphocyte Antigen 4 Are Refractory to Murine Acquired Immune Deficiency Sydrome Development. Immunology, 98 (4), 630-8. doi:10.1046/j.1365-2567.1999.00900.x Peer Reviewed verified by ORBi |
Nkoghe, D., Moutschen, M., Leonard, P., & Demonty, J. (December 1999). Pharma-clinics comment je traite ... une infection par le VIH. III. Les inhibiteurs non nucléosidiques de la transcriptase inverse. Revue Médicale de Liège, 54 (12), 909-11. Peer reviewed |
Nkoghe, D., Leonard, P., Moutschen, M., & Demonty, J. (December 1999). Pharma-clinics le médicament du mois. La nevirapine. Viramune. Revue Médicale de Liège, 54 (12), 948-51. Peer reviewed |
Radermecker, R., Nkoghe, D., Labasse, J. M., Moutschen, M., & Demonty, J. (January 1999). L'image du mois. Kyste hydatique hépatique. Revue Médicale de Liège, 54 (1), 4-5. Peer reviewed |
Trebak, M., Lambert, C. A., Rahmouni, S., Debrus, S., Defresne, M.-P., Regnier, D., Boniver, J., & Moutschen, M. (15 September 1998). Decreased Protein Levels of the C-Cbl Protooncogene in Murine Aids. Cellular Immunology, 188 (2), 151-7. doi:10.1006/cimm.1998.1348 Peer Reviewed verified by ORBi |
de Leval, L., Colombi, S., Debrus, S., Demoitie, M. A., Greimers, R., Linsley, P., Moutschen, M., & Boniver, J. (June 1998). Cd28-B7 Costimulatory Blockade by Ctla4ig Delays the Development of Retrovirus-Induced Murine Aids. Journal of Virology, 72 (6), 5285-90. doi:10.1128/jvi.72.6.5285-5290.1998 Peer Reviewed verified by ORBi |
 | Jacobs, N., MOUTSCHEN, M., Franzen-Detrooz, E., Boniver, V., Boniver, J., & Delvenne, P. (April 1998). Organotypic Culture of HPV-Transformed Keratinocytes: A Model for Testing Lymphocyte Infiltration of (Pre)Neoplastic Lesions of the Uterine Cervix. Virchows Archiv, 432 (4), 323-30. doi:10.1007/s004280050173 Peer Reviewed verified by ORBi |
 | al-Saleh, W., Giannini, S. L., Jacobs, N., Moutschen, M., Doyen, J., Boniver, J., & Delvenne, P. (March 1998). Correlation of T-Helper Secretory Differentiation and Types of Antigen-Presenting Cells in Squamous Intraepithelial Lesions of the Uterine Cervix. Journal of Pathology, 184 (3), 283-90. doi:10.1002/(SICI)1096-9896(199803)184:3<283::AID-PATH25>3.0.CO;2-K Peer Reviewed verified by ORBi |
Daniel, C., Baron, F., & Moutschen, M. (1998). Le cas clinique du mois. A propos d'une pancytopenie chez un patient seropositif. Revue Médicale de Liège, 53 (12), 732-4. Peer reviewed |
 | Jacobs, N., Giannini, S. L., Doyen, J., Baptista, A., Moutschen, M., Boniver, J., & Delvenne, P. (January 1998). Inverse Modulation of Il-10 and Il-12 in the Blood of Women with Preneoplastic Lesions of the Uterine Cervix. Clinical and Experimental Immunology, 111 (1), 219-24. doi:10.1046/j.1365-2249.1998.00437.x Peer Reviewed verified by ORBi |
 | Trebak, M., Lambert, C., Rahmouni, S., Greimers, R., Boniver, J., & Moutschen, M. (1998). Reciprocal regulation of protein tyrosine kinases p56lck and p59fyn, and altered tyrosine phosphorylation in murine AIDS. International Immunology, 10 (10), 1473-80. doi:10.1093/intimm/10.10.1473 Peer Reviewed verified by ORBi |
Moutschen, M., Nkoghe, D., Leonard, P., & Demonty, J. (December 1997). Pharma-clinics. Comment je traite ... Une infection par le VIH. II. Inhibiteurs nucléosidiques de la transcriptase reverse. Revue Médicale de Liège, 52 (12), 750-2. Peer reviewed |
Moutschen, M., Nkoghe, D., Leonard, P., & Demonty, J. (October 1997). Comment je traite ... une infection par le VIH. I. Bases pathogéniques des choix thérapeutiques. Revue Médicale de Liège, 52 (10), 622-4. Peer reviewed |
 | Jacobs, N., Mazzoni, A., Mezzanzanica, D., Negri, D. R., Valota, O., Colnaghi, M. I., MOUTSCHEN, M., Boniver, J., & Canevari, S. (July 1997). Efficiency of T Cell Triggering by Anti-Cd3 Monoclonal Antibodies (Mab) with Potential Usefulness in Bispecific Mab Generation. Cancer Immunology, Immunotherapy, 44 (5), 257-64. doi:10.1007/s002620050381 Peer Reviewed verified by ORBi |
Colombi, S., Moutschen, M., de Leval, L., Demoitie, M. A., Trebak, M., Martin, M. T., & Boniver, J. (February 1997). Peyer's Patches in Murine Aids: Dissociation between Lymphoproliferation and Anergy. Scandinavian Journal of Immunology, 45 (2), 175-81. doi:10.1046/j.1365-3083.1997.d01-390.x Peer Reviewed verified by ORBi |
 | Louis, E., Moutschen, M., de Marneffe, P., Malherbe, R., Closon, T., T'Jean, M., Demonty, J., & Belaiche, J. (1997). Extensive Ulcerative Colitis and Extraintestinal Manifestations in a Patient with Hiv Infection and Significant Cd4 T-Cell Lymphopenia. Gastroentérologie Clinique et Biologique, 21 (11), 884-7. Peer Reviewed verified by ORBi |
Moutschen, M., Trebak, M., Greimers, R., Colombi, & Boniver, J. (November 1996). Subset-Specific Analysis of Calcium Fluxes in Murine Aids. International Immunology, 8 (11), 1715-27. doi:10.1093/intimm/8.11.1715 Peer Reviewed verified by ORBi |
 | Jacobs, N., Greimers, R., Mazzoni, A., Trebak, M., Schaaf-Lafontaine, N., Boniver, J., & Moutschen, M. (July 1996). Further Characterization of Cytotoxic T Cells Generated by Short-Term Culture of Human Peripheral Blood Lymphocytes with Interleukin-2 and Anti-Cd3 Mab. Cancer Immunology, Immunotherapy, 42 (6), 369-75. doi:10.1007/s002620050296 Peer Reviewed verified by ORBi |
 | Greimers, R., Trebak, M., Moutschen, M., Jacobs, N., & Boniver, J. (01 March 1996). Improved Four-Color Flow Cytometry Method Using Fluo-3 and Triple Immunofluorescence for Analysis of Intracellular Calcium Ion ([Ca2+]I) Fluxes among Mouse Lymph Node B- and T-Lymphocyte Subsets. Cytometry, 23 (3), 205-17. doi:10.1002/(SICI)1097-0320(19960301)23:3<205::AID-CYTO4>3.0.CO;2-H Peer Reviewed verified by ORBi |
Moutschen, M. (June 1995). Pharma-clinics. Comment j'explore... une asthenie chronique. Revue Médicale de Liège, 50 (6), 268-9. Peer reviewed |
de Leval, L., Deprez, M., Colombi, S., Humblet, C., Defresne, M.-P., Boniver, J., & Moutschen, M. (1995). Morphological Changes of Thymus in Retrovirus-Induced Murine Acquired Immunodeficiency Syndrome (Maids). Pathology - Research and Practice, 191 (6), 506-12. doi:10.1016/S0344-0338(11)80869-1 Peer Reviewed verified by ORBi |
 | Nikkels, A., Collignon, J., MOUTSCHEN, M., Paquet, P., Bouillenne, C., & Pierard, G. (03 December 1994). Maladie de Kaposi chez une patiente souffrant d'une immunodéficience acquise VIH négative. Presse Médicale, 23 (38), 1760-1761. Peer Reviewed verified by ORBi |
 | Moutschen, M., Jacobs, N., Hoyoux, C., Martin-Simonet, M.-T., Schaaf-Lafontaine, N., & Boniver, J. (1994). Presence of gd TcR+ Tumor Infiltrating Lymphocytes (TILs) in One Case of Pediatric Osteogenic Sarcoma. International Journal of Pediatric Hematology/Oncology. Peer Reviewed verified by ORBi |
Moutschen, M., Colombi, S., Deprez, M., Greimers, R., Van Wijk, F., Hotermans, C., & Boniver, J. (1994). Lymphocyte Lifespan in Murine Retrovirus-Induced Immunodeficiency. Advances in Experimental Medicine and Biology, 355, 177-81. doi:10.1007/978-1-4615-2492-2_30 Peer Reviewed verified by ORBi |
 | Colombi, S., Deprez, M., de Leval, L., Humblet, C., Greimers, R., Defresne, M.-P., Boniver, J., & Moutschen, M. (1994). Thymus Involvement in Murine Acquired Immunodeficiency (Maids). Thymus, 23 (1), 27-37. Peer Reviewed verified by ORBi |
Moutschen, M., Triffaux, J.-M., Demonty, J., Legros, J.-J., & Lefebvre, P. J. (1994). Pathogenic Tracks in Fatigue Syndromes. Acta Clinica Belgica, 49 (6), 274-89. Peer Reviewed verified by ORBi |
 | Moutschen, M., Colombi, S., Deprez, M., Van Wijk, F., Hotermans, C., Martin, M., Greimers, R., & Boniver, J. (1994). Population dynamics of CD4+ T cells lacking Thy-1 in murine retrovirus-induced immunodeficiency syndrome (MAIDS). Scandinavian Journal of Immunology, 39 (2), 216-24. doi:10.1111/j.1365-3083.1994.tb03363.x Peer Reviewed verified by ORBi |
 | Jacobs, N., MOUTSCHEN, M., Boniver, J., Greimers, R., & Schaaf-Lafontaine, N. (February 1993). Efficient Immunoselection of Cytolytic Effectors with a Magnetic Cell Sorter. Research in Immunology, 144 (2), 141-50. doi:10.1016/0923-2494(93)80069-B Peer Reviewed verified by ORBi |
 | Boniver, J., Courtoy, R., Schaaf-Lafontaine, N., Martin-Simonet, M. T., Greimers, R., Rongy, A. M., Moutschen, M., Jacobs, N., Baudrihaye, M., Delvenne, P., Humblet, C., Lovens, D., Deman, J., Goffinet, G., & Defresne, M.-P. (1992). Cell Surface Receptors in Lymphoid Cells: From Cytochemistry to Molecular Biology and from a Phenotype to a Function. Progress in Histochemistry and Cytochemistry, 26 (1-4), 169-81. doi:10.1016/S0079-6336(11)80093-8 Peer Reviewed verified by ORBi |
Moutschen, M., Scheen, A., & Lefebvre, P. (1992). Impaired immune responses in diabetes mellitus: analysis of the factors and mechanisms involved. Relevance to the increased susceptibility of diabetic patients to specific infections. Diabète et Métabolisme, 18 (3), 187-201. Peer Reviewed verified by ORBi |
Boniver, J., Schaaf-Lafontaine, N., Moutschen, M., Longree, L., Lovens-Degraef, D., Fassotte, M. F., Reginster, M. A., Simonet-Martin, M. T., & Baudrihaye, M. (01 February 1990). Réalisations et perspectives de l'immunothérapie du cancer. Revue Médicale de Liège, 45 (2), 41-8. Peer reviewed |
Beguin, Y., Fassotte, M.-F., Hay, F., Dokekias, A., Andrien, F., Bours, V., Moutschen, M., Runde, V., Bury, J., & Fillet, G. (1990). Greffes de moelle osseuse: bilan au CHU de Liege. Revue Médicale de Liège, 45 (6), 268-79. Peer reviewed |
Mendes, P., Andrien, F., PAQUOT, N., MOUTSCHEN, M., SCHEEN, A., D'ORIO, V., & Lefebvre, P. (1989). Traitement inhabituel de la thyreotoxicose. Acta Clinica Belgica, 44, 71. Peer Reviewed verified by ORBi |
Bontemps, J., Grandfils, C., MOUTSCHEN, M., Dandrifosse, G., & Schoffeniels, E. (25 March 1984). Experimental set up of a fast gel filtration technique for the determination of the binding of a chemically labelled form of tetrodotoxin to its solubilized receptor from excitable tissues [Poster presentation]. 125e Réunion de la Société Belge de Biochimie, Rhode Saint Genèse, Institut de Biologie Moléculaire. |
 | Bontemps, J., Grandfils, C., Moutschen, M., Dandrifosse, G., & Schoffeniels, E. (1984). Experimental set up of a fast gel filtration technique for the determination of the binding of a chemically labelled form of tetrodotoxin to its solubilized receptor from excitable tissues. Archives Internationales de Physiologie et de Biochimie, 92, 8-9. Peer Reviewed verified by ORBi |
